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Abstract 
 
Synthesis of Pyranobenzopyrans 
 
Sumiea B. Eltayeb 
Doctor of Philosophy in Chemistry 
Seton Hall University Dr. Cecilia H. Marzabadi, Advisor 
 
            Carbohydrates  and  their  derivatives  are  involved  in  a  wide  array  of  
biological  processes  and  are  crucial  for  the  survival   of  living  entities. As  a  result,  
sugar-based  compounds  have  become  attractive  scaffolds  for  drug  design.  In  
addition,  pyranobenzopyran   derivatives  have  shown  promise  in  the  treatment  of  
numerous  health  conditions   such  as    anticoagulants,  antifungal,  and  anti-
inflammatory  agents.  They  have  also  shown  important  properties  as  antibiotics    
anti-AIDS  agents)  and  antitumor  drugs.                                                                   
The  main  point  of  our  research  was  to  determine  and  develop  a  synthetic  
method  for  the  preparation  of   pyranobenzopyrans  and  carbohydrate  fused  
heterocyclic  compounds. This  was  accomplished  via  a  [4+2]  cycloaddition  reaction 
to  generate  the  oxygen-containing  six-membered  ring  by  the addition  of  the  imine 
o-hydroxybenzaldimine  and  its derivatives  to  glucals  in  organic  solvent  under   
catalysis  by  scandium  triflate. The  conventional  method  and  microwave  reactor  
method  were  initially  used  to  achieve  this goal,  but  no  reaction  was  observed.  
The  failure  of  these   reactions  may  be due  to  the  sugar  protecting  group  such  
as  the acetyl  ester.  Acetyl could  deactivate  electronically, where  benzyl  and  
 xi 
 
butyldimethylsilyl  ethers  created  steric  hindrance  and  inhibited  the  reaction. Then  
new  methodology  was  developed  and  an ionic  liquid  was  used  as  a solvent  to  
dissolve  the  D-glucal  and  the  other  reactants.  A series  of  pyranobenzopyrans  
have  been  prepared  via  Lewis  Acid  catalyzed  cycloaddition  reactions  of  D-glucal  
and  o-hydroxybenzaldehyde  and  its  derivatives  in  room  temperature  imidazolium  
ion-based  ionic  liquid  solvents. Different  o-hydroxybenzaldehyde  derivatives  were  
tested  to  study  the   effect  of  the  substituents  in  the  rate  of  the  reaction.  Four 
products were  obtained  in  poor  to  moderate  yields. Because  2-hydroxy-5-
nitrobenzaldehyde,  2-hydroxy-5-methylbenzaldehyde  and  2,5-dihydroxybenzaldehyde  
were  insoluble  in  the  ionic  liquids,  no  product  was  obtained  from  their  reaction  
with  D-glucal. Danishefsky’s  Diene,  1-methoxy-3-trimethylsiloxy-1, 3-butadiene,  was  
also  reacted  in  ionic  liquid  and  the  product  2-5,8a-dihydroxy-1(hydroxymethyl)-
1,4a, 5, 6, 7,8a-hexahydro-8H-isochromenone  was  obtained  in  moderate  yield. In 
these reactions,  the  glycal  itself   was  found  to  serve  as  a diene   with  another  
molecule  of  glycal  as  the  dienophile to  form  an  interesting  sugar  dimer.                                                                                                 
All the structures prepared were confirmed by NMR and elemental  analyses.   
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Chapter 1 
 
                                                         Introduction 
 
 
1.1. Carbohydrates 
1.1.1. General Structure and Properties of 
carbohydrates                                                                                                                                 
The  term  carbohydrates  was  originally  derived  in  the  nineteenth  century  from  the 
French  term (hydrate  de  carbon)  for  the  family of  the  compounds  possessing  the  
empirical  formula  Cn (H2O)n.1 Carbohydrates  are a  unique  family  of  poly functional  
molecules;  they  exist  as  monosaccharide  building  blocks  that  are  linked  together  
in  almost  limitless  ways  to  form  oligosaccharides  and  polysaccharides.2  
Monosaccharides  are  polyhydroxy - aldehydes  or  ketones. The most  common  types  
of  structures  are  aldoses  (Figure 1.1)  and  consist  of  linear  carbon  chains  with  an  
aldehyde  (CHO )  group  at  C-1  and  varying  number  of  carbon  atoms  that  are  
secondary  alcohols  (CHOH),  and  a primary  alcohol  (CH2OH)  at  the   terminal  end. 
Ketoses  ( Figure 1.2)  have a  primary  alcohol  at  both  ends  and  have  a ketone  
carbonyl (C=O)  within  the  chain at C-2.2   
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Figure 1.1.  Aldoses General Structure.               Figure1. 2. Ketoses General Structure. 
                                                                                                            
 
The  simplest  example  of  an  aldose  is  glyceraldehyde  that  consists  of  three  
carbons. Higher  sugars  containing  four  carbons  are  known  as  tetroses,  five  
carbons  pentoses,  and  six  carbons  hexoses  (Figure 1.3).   
Figure 1.3 Example of Aldoses. 
  
                                                                      
 Glyceraldehyde            Tetrose                     Pentose                    Hexose     
Figure 1.4. Example of Ketoses  
  
                                                                        
 Dihydroxyacetone      Ketotetrose                    Ketopentose               Ketohexose                                
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Each  of   the  carbon  atoms  that  are  secondary  alcohols  have  four  different  
groups  attached  and  are  stereogenic  (or chiral)  centers,  giving  rise  to  
stereoisomers. Although  the  stereoisomeric  diversity  is  often times  problematic  and 
the  chemistry  of  carbohydrates  present  numerous  challenges,  their  widespread  
presence  in  biological  systems makes  them  attractive  targets  for  continued   
research,  especially  in  the  field  of  therapeutics.3   In  addition,  carbohydrate  
products  are  utilized  in  food,  clothing, and  the  agrochemical  industry.4 The  
importance  of  carbohydrates  to  living  things  can  hardly  be  overemphasized. The  
energy  stores  of  most   animals  and  plants  are  both  carbohydrate  and  lipid  in  
nature;  carbohydrates   are   generally  available  as  an  immediate  energy  source,  
Glucose,  the  prevalent  uncombined,  or  free,  sugar  circulating  in  the  blood  of   
higher  animals,  is  essential  to  cell  function. The  proper  regulation  of  glucose  
metabolism  is  of  paramount  importance  to  survival.3                                                                                                                                                              
1.1.2 The Structure and Properties of Glucose.                                                                                                                                
The  structure  and  properties  of  glucose   will  be  considered  in  greater  detail  than  
those  of  the  other  monosaccharides.  Glucose  is  an  aldohexose,  which  means  
the  structure  has  a  six-carbon  sugar  with  a  terminal  aldehyde  group. From  the  
formula  C6H12O6  sixteen  possible  configurational  isomers  are  known- some  occur  
naturally  and  the  others  have  been  synthesized. This   problem  of  identifying  
glucose  as  a particular  one  of  the  sixteen  possibilities  was  solved  by  Emil  
Fischer  during  the  latter  part  of  the  nineteenth  century, and  he  was  awarded  the  
Nobel  Prize  in  chemistry  in  1902.4  Fischer  established  the  fundamental  
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groundwork  that  provides  the  basis  of  the structure of the   enantiomer  of  natural  
glucose  shown  in  the projections  of  the  formula 1  and  formula 2.   
 
                                                     
            1                                                  2 
 
The  great  difficulties  of  working  with  carbohydrates, are:  their  considerable  
solubility  in  water, their  instability  to  strong  oxidizing  agents  and  acidic  or  basic  
reagents,  their  reluctance  to  crystallize,  and  their  tendency  to  decompose  rather  
than  give  sharp  melting  points.4 
1.1.3. Ring Structure of Monosaccharides                                                                                             
Any  given  mixture  of  an  aldehyde  and  alcohol  is  in  equilibrium  with  a hemiacetal, 
a process  which  forms  a  new  stereogenic  center . Since  carbohydrates  have  both  
carbonyl  and  hydroxyl  functions  they  are  capable  of  forming  intramolecular  
hemiacetals,  known  as  lactols.2  The  cyclic  form  occurs  because  of  a  nucleophilic  
addition  reaction  between  the  hydroxyl  group  of  C-4  or  C-5  and  the  carbonyl  
functionality  at  C-1. Either hemi-acetals or hemi-ketals form, depending on the type of  
sugar.  
1.1.4. Six-Membered Cyclic Pyranoses and Five-Membered Cyclic Furanoses.                      
Pyranoses  and  furanoses  forms  are  further  subdivided on  the  basis  of  how  they  
 5 
 
cyclize. During  the  cyclization,  the  anomeric  carbon                                                               
(the  hemiacetal  carbon  atom  originating  from  the  carbonyl  oxygen)  becomes  a 
sterogenic  center   with  two  possible  configuration  α  or  β. (figure 1.5)  depending  
on  the  way  they  cyclize. The  resulting  isomers  are  called  anomers  and  the 
interconversion of the anomers in solution  called  mutarotation.  Mutarotation  is  the  
change  in  optical  rotation  that  occurs  by  epimerization  at  the  anomeric  center.  
That  means,  it  is  the  change  in  the  equilibrium  between  two  anomers,  when  the  
corresponding  stereocenters  interconvert.  Cyclic  sugars  show  mutarotation  as  α  
and  β  anomeric  forms  interconvert. In  aqueous  solution,  D-glucose  exists   as  a  
mixture  of  38%  α  and  62%  β (Figure 1.6).  The   β  is  favored  because  all of  the   
hydroxyl  group  are  in  equatorial  position  on  the  ring, while  in  α  anomer, one  
hydroxyl  group  is  forced  into  the  axial  position  which  causes  higher  energy  in  
the  molecule  and  makes  it  less  stable.2         
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Figure 1.5.  Configuration of the Hydroxyl Group at the Anomeric Carbon 
                                                                                                 
                                                                     
                                                                         
                                                                                                       
 
 Another  equilibrium  process  that  is  characteristic  of  sugars  is  conformational  
interconversion  of  the  cyclic  ring.  where  the  six-  membered  ring  can  undergo  an  
equilibrium  between  different  chair  conformations. For glucopyranose, the 4C1  
conformation  is  preferred  because  all  the  hydroxyl  group  substituents are in  the 
equatorial  position  while  1C4  conformation  has  all  the  hydroxyl  groups  in  the  
axial  position.   
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Figure 1.6. Conformational Conversion of the Cyclic ring 
 
                                                                       
                                 4C1                                                                                   1C4       
 
1.1.5. The Biological Importance of Sugars.   
Carbohydrates  are  one  of  most  abundant  biomolecules  on  the  Earth  and  they  
are  involved  in  many  essential  biological  processes:  they  act  as  an  energy  
source,  in  biological  signaling  and  recognition  mechanisms  and  as  basic  
structural  building  blocks  controlling  the  architecture  of  nature. For  example,  
sugars  are  integral  parts  of  DNA,  RNA, starch,  cellulose  and  chitin  (insect  and  
lobster shells). D-glucose is central to several biochemical pathways. For  example,  it  
is  the  major  fuel  of  most  organisms  and  occupies  an  essential  position  in  both  
anabolic  and  catabolic  reactions. Glucose  is  the  product  of  photosynthesis  carried  
out  by  plants  whereby  energy  from  sunlight  is  converted  into chemical  bonds  
(Scheme 1).6 
Light + 6H2O + 6CO2       C6H12O6 (glucose) + 6CO2  
  Glucose is a building  unit  for  many  disaccharides,  for  example  sucrose  
(commonly  known  as  table  sugar)  consists  of  glucose  and  fructose. Starch is a 
polymer of glucose units,  consisting of  a mixture  of  amylose (linear)  and  
amylopectin (branched),  is  used  in  plants  for  energy  storage.  It is found  in  the  
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tuber, roots, fruits  and  seeds  of  plants. Glycogen  is  a highly branched, high 
molecular weight  polymer  of  D-glucose  that  is  the  mammalian  counterpart  to  
starch. It  serves  as an  abundant  energy  storage  form  of  carbohydrates,  and  
occurs  widely  in  nature.2  Sugars  can also  play  important  roles  in  other  biological  
activities  such  as  signals  communication  both  within  and  between   cells.1  The  
correct  carbohydrate  structures  on  cell  surfaces  are  also  necessary  for  the  
fertilization  of  eggs  by  sperm  and  for  development  of  embryos. 1Many  
carbohydrates  in  the  cell  are  covalently   bound  to  proteins or  lipids that  are  
coated  on  the  surface  of  the  cells  where  they  act  as  recognition  molecules  for  
viruses,  and  other pathogens.7    
Complex carbohydrates are chains of monosaccharides,  often  called  glycans.The  
carbohydrates  attached  to  proteins  are  known  as  glycoproteins,  whereas  the  
ones   conjugated  to  the  lipids  are  glycolipids.,  Glycans  are  involved  in  a variety  
of  biological  processes  including  protein  folding  and  signaling  events.  Unlike  
DNA  and  proteins,  however,  monosaccharides,  may  be  linked  to  one  or  more  
other  monosaccharides,  such  that  they  form  a branched  tree  structure.6                                                                        
1.1.6. Carbohydrate-Based Drugs.  
A  relatively  untapped  source  of  new  chemical  entities  of  drugs  comes  from  the 
area  of  functional  carbohydrates.  All  cell  surfaces  are  coated  with  complex  
carbohydrates  which  extend  much  further  out  from  the  cell  than  the  protein  
layer. These  intricate  molecules    act  as  recognition  molecules,  not  just  for  other  
cells,  but  also  for  pathogens  that  must  identify  and  bind  specific  cell  types  for  
successful  infection.  On  the cell  surface,  they  form  layers  known  as  glycocalyx  
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ranging  from  10  to   100  nm  in  thickness  and  thus  extending   much  further  out  
from  the  cell  surface  than  proteins. 7                                                                      
These  O-  and  N-glycans  are  present  in  many  different  molecular  forms  including  
glycoproteins,  proteoglycans,  glycolipids,  and  glycophosphatidylinositol-linked  
proteins. Their  broad  diversity  originates  from  their  assembly  from  monosaccharide  
building  blocks,  which  can  be  linked  with  others  at  various  positions  on  their  
pyranose/furanose  rings.  In  addition,  branched  structures  are  formed   because  
each  ring  can  establish  several  linkages.8  Finally,  the  density  of  structural  
information  is  further  increased  by  the  possibility of  α-  and  β-isomers  at  the  
anomeric  center.  These chemical characteristics  bestow  carbohydrates  with  optimal  
properties  that  are  desired  for  recognizing molecules.  Certain proteins  (called  
lectins)  have  evolved  three-dimensional  domains (called carbohydrate-recognition  
domains  CRD)  that  can  bind  specific  carbohydrate  structures  and  thus  decode  
this  information.8  Cell  surface  carbohydrates  involved  in  specific  cell-  to-  cell  
recognition  exhibit  biological  phenomena  like  cell  adhesion,  cell activation,  
inflammatory  migration,  neurite  outgrowth,  and  cancer  metastasis.1 Pathogens  
including   viruses,  bacteria,  and  even  parasites  infect  their  host  cells  by  
recognizing  and  binding  to  specific  carbohydrates  and  cell surfaces,  Perhaps  the  
most  popular  examples  are  the  influenza  viruses,  which  are  designated  by  viral  
coat  proteins  hemagglutinin  (H)   and  neuraminidase  (N).    Both  of  these  viral  
proteins, in  fact,  bind  specific  carbohydrate  sequences  on  the  host  cell  surfaces,  
Antibodies  that  recognize  carbohydrates  and  promote  disease  are   identified  as  
therapeutic  targets  in  autoimmune  disease.9 “The  identification  of  functional  
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carbohydrate  epitopes  and  their  corresponding  specific  carbohydrate-binding  
proteins  as  new  targets  for  drug  development  is  emerging  at  a  rapid  rate  due to  
concerted  worldwide  efforts  to  organize  and  support  technologies   for   elucidating  
the  human  “glycome”.9  While  carbohydrates  act  as  excellent  recognition  
molecules  on  cell  surfaces,  many  of  their  intrinsic  properties  make  them  poor  
choices  for   small  molecule  drugs.10  In  many  cases  the  binding  affinities  of  
monovalent  carbohydrates  are  in  the  millimolar  to  micromolar   range  and  are  
therefore  relatively  weak  and  usually  not  adequate  to  complete  with  multivalent  
interactions.  The  general  hydrophilic  nature  of  carbohydrates  and  their  higher  
density  of  hydroxyl  groups  work  against  the  lipophilicity  required  for  passive  
absorption  through  the  intestine.8                                                                              
1.1.7.  The Application and the Categories of Carbohydrate Drugs.                                      
The  pharmacokinetic  properties  of  absorption,  distribution,  biotransformation  and  
excretion  are  important  areas  of  focus  in  the  field  of  drug  discovery. This  is, 
especially  true  when  dealing  with  sugar-based  compounds.10  The  ability  to  
generate  structure  activity  relationship  (SAR)  data  while  balancing  stability,  
solubility,  molecular  weight,  lipophilicity  and  metabolism  is  extremely  important  in  
the  “hit  to  lead”  process,  Although  high  throughput  methodology  and  
combinatorial  libraries  hold  many  advantages  for  drug  discovery,  natural  product  
modification  has  the  potential  to  provide  improved  structures  for  drug  discovery  
and  to  provide  improved  structural  diversity.  Often, sugar-based compounds have 
enhanced activity against specific targets.3                                                                                                                                  
 11 
 
A few dozen FDA-approved prescription drugs contain carbohydrate. Moieties   as part 
of their structures. These drugs can be divided into five categories, listed below: 
1- Monosaccharide Conjugates.                                                                                                              
2- Disaccharides and their Conjugates.                                                                                                         
3- Trisaccharides and their Conjugates.                                                                                                       
4- Oligosaccharides and Polysaccharides                                                                                     
5- Macrolides    
 1.1.7.1. Monosaccharide Conjugates                                                                                                  
Monosaccharide Conjugates can be divided into four groups:.                                                          
1) Anthracycline  antibiotics 26  and  agents, 2)  Nucleotides  and  nucleosides   and  
their  analogs  (for  example  an  antitumor  drug, 3)  polyenes  and  the forth group of  
monosaccharide  drugs  that  contains  a  number  of  assorted  compounds such as 
Pentostatin 27,  that  inhibits  RNA  and  DNA Synthesis  by  being  a  direct  inhibitor  of  
enzymes  adenosine  deaminase  and  ribonucleotide  reductase,  particularly  in  cells  
of  the  lymphoid  system).12,13 
 Figure 1.7.  Monosaccharide Conjugates 
 
                           
                    26                                                                       
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 1.1.7.2. Disaccharides and their Conjugates.                                                                                     
The  next  subcategory  of  prescription  carbohydrate  drugs  is disaccharides  and  
their  conjugates.  A  good  example  of  these  is  sucralfate 28, which  is  a  β-D-
fructofuranosyl-α-D-glucopyranoside  basic  aluminum  sucrose  sulfate  complex. It  
accelerates  healing  of  duodenal  ulcers,  in  part  by  inhibiting  pepsin  activity  in  
gastric  juice.  A synthetic colonic acidifier Lactulose 29,  (Figure 1.8) 4-O-β-D-
galactosyl-D-fructose, promotes laxation.12                                                                                                         
Figure 1.8. Disaccharides and their Conjugates.  
 
 
                            29 
1.1.7.3. Trisaccharides and their Conjugates 
The  third  category,  trisaccharides  and  their  conjugates,  is  represented  by  two  
prescription  drugs;  an  antibacterial  aminoglycoside  antibiotic  of  microbial  origin, 
Tobramycin,  and  a  cardiac  glycoside, Digoxin 30. The  latter drug  belongs  to  a 
closely  related  group  of  drugs  of  plant  origin  that  contains  a  sugar  and  a  
cardenolide; the  sugar  part  consists  of  O-2,6-dideoxy-β-D-ribo-hexapyranosyl- (1-
>4)-O-2,6-dideoxy-beta-D-ribo-hexapyranosyl-(1->4)-2 ... -.13 
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Figure 1.9. Trisaccharides and their Conjugates. 
 
 
                                               30  
 
1.1.7.4. Oligosaccharides and Polysaccharides. 
Oligosaccharides  are  saccharide  polymer  containing  a small  number  typically  two 
to  ten  of  simple  sugars  (monosaccharides). and   polysaccharides  are  complex  
carbohydrates  consist  of  more  than  ten  of  monosaccharides. The  main 
monosaccharides  in  their  building  blocks  are  glucose,  fructose  and  galactose,2  
also  known  as  simple  carbohydrates. Prescription  drugs  made  of  oligosaccharides  
and  polysaccharides  include  two  principal  groups,  heparin  and  heparin-like  
saccharides.  Heparin  is  a  heterogeneous  group  of  glycosaminoglycans,  straight-
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chain  anionic  mucopolysaccharides  that  have  anticoagulant  activity. Pentosan 31 
polysulfate is a semi-synthetic sulfated heparin-like oligomer. Composed  of  β-D-
xylopyranose  residues,  it  shows  anticoagulant  and  fibrinolytic  effects.12 The  
complex  oligosaccharides, can  be  represented  by   acarbose 32. This compound 
derives from a microbial origin. It  inhibits  α-glucosidase  and  delays  the  digestion  of  
ingested  carbohydrates,  making  the  drug  beneficial  for  the  management  of  type 2  
diabetes  mellitus.12 
 Figure 1.10. Oligosaccharides and Polysaccharides. 
 
          
                                  31 
 
 
 
                                      32 
 
 
 
 15 
 
1.1.6.5. Macrolides.                                                                                                                        
The  final  subcategory  of  prescription  carbohydrate  drugs  is  represented  by 
macrolide  group  of  antibiotics.  Erythromycin 33,  is  of  microbial  origin;  it  appears  
to  inhibit  protein  synthesis  in  susceptible  organisms  by  binding  to  ribosomal  
subunits  and  thereby  inhibiting  translocation  of  aminoacyl  transfer-RNA. The  other  
three  Clarithromycin 34,  Dirithromycin 35,  and  Azithromycin 36  are  semi-synthetic  
macrolide  antibiotics  derived  of  Erythromycin.  Dirithromycin  is  a pro-drug  that  is  
transformed  during  intestinal  absorption  into  an  anti-bacterial  active  form,  
Erythromycylamine. Clarithromycin is 6-O-methylerythromycin. Azithromycin is                     
N-methyl-11-aza-10-deoxo-10-dihydroerythromycin”.12,13 
  Figure 1.11 Macrolides 
 
                             
                    33                                                                                              34 
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1.1.6.6. Summary.                                                                                                             
Carbohydrates are the most abundant molecules in natural products. The  word  
carbohydrate  is  derived  from  the  observation  that  simple  sugars  are  hydrates  of  
the  element  carbon. Carbohydrates  are  main  energy  source  for  mammals,  the  
major  constituents  of  the  shells  of  insects,  and  the  supporting  tissue  of  plants. 
Carbohydrate  chemistry  has  been  a  topic  of  interest  and  carbohydrate  derivatives  
are  attractive  for  drug  design  because  of  their  unique  structure  and  biological  
activity. Cell  surface  carbohydrates  are  involved  in  recognition,  fertilization,  signal  
transduction,  Multiple  stereocenters  and  numerous  hydroxyl  functional  groups  
make  carbohydrates  a  diverse  class  of  structurally  unique  compounds. Glucose  is  
biologically-significant  monosaccharide  involved  in  metabolic  and  energetic  
pathways.  A  large  number  of  carbohydrates  and  carbohydrates  derivatives  are  
used  as  therapeutics. Understanding  the  bioactive  conformation  of  sugars  and  
carbohydrates-protein  interactions,  allows  for  the  rational  design  of  small  drug-  
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like  molecules  with  increased  affinity,  stability,  and  bioavailability.  In  addition to  
therapeutics,  carbohydrates  are  important  in  the  paper  and  textile  industries. As  
the  result  of  the  prevalent  importance  of  carbohydrates,  there  is  a  significant  
future for  basic  research  involving  carbohydrates. 
1.2. Benzopyrans.                                                                                                                       
1.2.1. General structure and properties of benzopyrans.                                                               
The  chemistry  of  heterocyclic  compounds  is  one  of  the  most  complex  branches 
of  organic  chemistry. It  is  equally  interesting  for  its  theoretical  implications, for  the  
diversity  of  its  synthetic  procedures,14  and  for  the  physiological  and  industrial  
significance  of  heterocyclic  compounds.  Among  all  heterocyclic  compounds, 
oxygen  heterocycles  are  special  because  of  their  wide  occurrence  in  nature  and  
broad  pharmaceutical  significance. Benzopyrans  appear  as  an  important  structural  
components  in  various  natural  products,  and   mainly  consist  of  a  benzene  ring  
fused  to  a pyran  ring.15   Benzopyrans  can  be  classified  according  to  their  various  
levels  of  saturation  and  oxidation,  namely  ,  chromane 37,  2H-chromene 38,        
1H-isochromene 39,   4H-chromene] 40,  4- chromanone 41,  2,4-chromanedione 42,  
and  chromone 43  
Figure 1.12. Examples of Different Levels of Saturation and Oxidation of Chromanes 
 
                         
           37                                38                           39                            40 
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        41                                    42                                             43 
In  addition  to  functional  derivatives  of  these  ring  systems,  compounds  in  which  a  
benzene  or  other  carbocyclic  ring  is  fused  to  the  benzene  ring  for  example, 
benzochromones 44,  naphthopyrans 45,  reduced  chromones 46  and  spiro  
compounds 47  are  also  common  in  nature.14 
 
                                                      
            44                                                     45                                               46 
 
                                                                
 
             47    
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1.2.2. Benzopyran Biological Activities. 
 Benzopyrans  (Chromenes)  are  one  of  the  privileged  medicinal  pharmacophores  
that  appear  as    important  structural  components  in  natural  compounds  and  have  
generated  great  attention  because  of  their  interesting  biological  activity.15 It  is  a 
heterocyclic  ring  system  consisting  of  a  benzene  ring  fused  to  a  pyran  ring. 
Chromenes  constitute  the  basic  backbone  of  various  types  of  polyphenols  and  
widely  found  in  natural  alkaloids,  tocopherols,  flavonoids,  and  anthocyanins.16  It  is  
known   that  certain  natural  and  synthetic  chromene  derivatives  possess  important  
biological  activities  such  as:  antitumor  (Catechin) 48 ,  antibacterial  ( Hongoqercin) 
49   antivascular,17  antiviral ,  antimicrobial,18  antioxidant,19  (Tocopherol) 50 , as TNF-
α  inhibitors,20  antifungal,  (Siccanin) 51.21  anticoagulant,  antispasmolytic,22   
estrogenic,22  antiviral,23  anti-helminthic,24  anticancer,24  anti-HIV  (Calanolide A) 52,25  
antitubercular,26  anti-inflammatory,27  herbicidal,  analgesic  and  as  anticonvulsants.28   
A key  feature  is  that  the  lipophilic  nature  of  the  benzopyran  derivatives  helps  
them  to  cross  the  cell  membrane  easily.29, 30  
Figure 1.13.  Examples of biologically active compounds. 
 
                                                        
               48                                                                                       49 
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12.2.31. Anticancer Activity Of Chromenes.  
Cancer  constitutes  the  second  main  mortality  cause  in  the  world.31  Cancer  is  a 
disease  characterized  by  the  uncontrolled  growth  of  abnormal  cells. It  is 
documented  that  the  most  cytotoxic  anticancer  agents  induce  apoptosis  which  is  
programmed  cell  death.  Chromene  derivatives  are  an  attractive  template  for  the  
identification  of  potential  anticancer  agents.32 In  recent  years,  there  has  been  
much  interest  in  this  class  of  compounds  and  their  potential  utility  as  anti-cancer  
drugs. Many  natural  compounds  contain  chromene  moieties  that  have  been  
reported  with  anticancer  activity. These compounds are isolated from plants, fish, etc. 
Some  of  the  examples  of  natural  anticancer  compounds  include  tephrosin,33  (lung  
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cancer)   calanone,34,35  (leukemia  and  cervical  carcinoma)  and acronycine36  (lung,  
colon  and ovary cancer). The  potential  pro-apoptotic  chemotherapeutic  agents   
target  tubulin,  bind  to  the  different  sites  of  tubulin  and  inhibit  tubulin  
polymerization.37 This  has led  to  the  discovery  of  new  structural  classes  of  
compounds  capable  of  binding  to  the  colchicine  site  of  tubulin. The  drugs  under  
this  category  that  binds  to  the  colchicine  binding  site  of  tubulin  resulting  in  the  
deformation  of  the α, β- dimer  structure  that  prevents  the  tubulin  from  assembling  
into  microtubules  leading  to  apoptotic  cell  death. 38,39  Substituted  4-aryl-
4Hchromene  compounds  belongs  to  a  novel  class  of  microtubule  inhibitors  and  a  
systematic  change  in  the  substitution  of  4-aryl  group  increases  the  anticancer  
activity  of  the  compound.40,41  Examples of  compounds  coming  from  this  category  
are  2-amino-4-(3-bromo-4,5-dimethoxyphenyl)-7-(dimethylamino)-4H-chromene-3-
carbonitrile 53  and  2-amino-7-(dimethylamino)-4-(7-methoxy-1,3-benzodioxol-5  54. In 
the above  compounds,  2-amino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene-3-
carbonitrile  53  induces  caspase-mediated  apoptosis  in  tumor  cells  and  is  more  
potent  than  the  commonly  prescribed  anticancer  alkaloids. Furthermore,  this  
compound  treats  drug-resistant  cancers  and  also  possesses  vascular  targeting  
activity.42  to  developed  this  type  of  compound,  combretastatin A-4  which  is  a 
phosphate  prodrug  (CA-4P), was  used  as  a lead  compound  because  of  its  simple  
structure  and,  potent  cytotoxic  and  vascular  disrupting  activity.23, 37  Bcl-2  protein  
binding  compounds  also  provide  lead  compounds  for  the  development  of  
potential  anticancer  agents. Substituted  4H-chromene  compounds  bind  to  Bcl-2 
protein  (β cell lymphoma)  and  induce  apoptosis  in  tumor  cells.20  Ethyl 2-Amino-6-
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Bromo-4-(1-Cyano-2- Ethoxy-2-Oxoethyl)-4H-Chromene-3-Carboxylate  (HA14-1) 55  is  
an  antagonist  for  antiapoptotic  Bcl-2 proteins  and  has  been  used  to  overcome  
drug  resistance  in  cancer.38 
Figure 1.14.  Examples of Microtubule Inhibitors.   
 
                                            
                 54                                                                                           53            
            
 
                 55           
The  SAR  studies  of  the  chromene  nucleus  found  that  the  4-aryl  moiety,                         
3-cyano  group  and  2-amino  group  are  all  essential  for  cytotoxic  activity.24,40  The  
replacement  of  the  2-amino  group  with  the  oxo  group  gives  the  same  activity  
and  helps  in  the  synthesis  by  removing  the  chiral  center.43  Substituting  the  
seven  position  with  an  electron  donating  group  enhances  the  potency  of  the  
compound  while  an  electron  withdrawing  group  in  that  position  decreases  the  
activity. 
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 1.2.4.3. Summary.                                                                                                                                                     
Benzopyran  is  one  of  the  privileged  scaffolds  that  appears  as  an  important  
structural  component  in  various  natural  products  and  also  possesses  useful  
photochemical  properties. The  derivatives  of  the  benzopyran  moiety  can  be  
capable  of  interacting  with  a variety  of  cellular  targets  which  leads  to  their  wide  
ranging  biological  activities  such  as  antitumor,  antihepatotoxic,  antioxidant,  anti-
inflammatory, diuretic,  anticoagulant,  antispasmolytic, estrogenic,  antiviral, antifungal,  
antimicrobial, anti-helminthic, hypothermal,  vasodilatory,  anti-HIV, antitubercular,  
herbicidal,  anticonvulsant  and  analgesic  activities. The  potency  of  these  clinically  
useful  pharmacophores  in  the  treatment  of  cancer  and  inflammation  and  other  
activities  encouraged  us  to  develop  ways  to  synthesize  these   significant  
compounds.                                                                   
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Chapter 2 
 Pyranobenzopyrans 
 
2.1. Overview  and  Historical  Perspective                                                                                                                                     
Coumarin  derivatives  (pyranobenzopyrans)  have  revealed  promising  biological  
activity  with  interesting  potential    therapeutic  applications44  besides  their  traditional  
use  as  anticoagulants,45  antifungal,46  anti-inflammatory  agents.47  They  have  also  
shown  important  property  as  antibiotics  (novobiocin) 56,48  anti-AIDS  agents 
(calanolides) 57.47  and  antitumor  drugs.49,50                                                                                                                                                 
Figure 2.0. Examples of  Coumarin  bioactive  compounds.                  
                     
                                   56                                                                                57 
 
The  biological  activities  of  pyranobenzopyrans  and  their  derivatives  has  made  
their  synthesis  very  important. Although  numerous  prescription  medicines  are  
available  for  the  treatment  of  human  disease,  medicinal  chemist  are  continuously 
searching  for  compound  with  improved  efficacy.                                                                                                                        
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2.2. Synthetic  Approaches  to  Pyranobenzopyrans  and  their  Derivatives  in  
Literature                                                                                                                                     
2H-1-Benzopyrans  (2H-chromenees)  and  3,4-dihydro-2H-1-benzopyrans  
(chromanees)  have  proven  to  be  very  important  due  to  the  biological  activity  of  
naturally  occurring  representatives.51  4-Aminobenzopyrans  and  their  derivatives  
show  a wide  range  of  biological  activities.52  Particularly, fused  
tetrahydropyranobenzopyran derivatives  are  frequently  found  in  naturally  occurring  
bioactive  molecules. In 1999, Miyazaki and co-workers  reported  a p-toluenesulfonic  
acid-catalyzed  intramolecular [4+2]  cycloaddition. Reaction  of  o-quinonemethides  for  
the  synthesis  of  angularly  trans-fused  pyranobenzopyrans.53  The  aza-Diels–Alder  
reaction  of  o-hydroxybenzaldimines  with 3,4-dihydro-2H-pyran  (DHP)  and  2,3-
dihydrofuran  (DHF)  is  a convenient  protocol  for  the  synthesis  of  fused  
pyranobenzopyrans  and  furanobenzopyrans.54,55  Several  protic  acids  and  Lewis  
acids  have  been  used  to  catalyze  this  reaction, such  as   LiBF4,56                          
PPh3-HClO4,57  and  Bi(OTf)3.58  Although  these  methods  are  available,  new, 
efficient,  selective,  and  facile  protocols  are  still  in  strong  demand. In  the  
literature,  much  work  has  been  done  in  this  field,  we  report  some  examples.                                                                                          
2.2.1. Facile, Solvent-free, One-Pot  Synthesis  of  Pyranobenzopyrans  and  their 
Derivatives                                                                                                                                     
In  May  2011,  Sirisha  and  her  group  have  developed  a  sequential  one-pot  
reaction  for  the  synthesis  of  verity  of  substituted  pyranobenzopyrans  by  
condensation  of  hydroxyl  coumarins  in  a  facile  one-pot  procedure  with  active  
methylene  esters  under  solventless  conditions. The  product  underwent  further  
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condensation  and  cyclization  reactions  to  form  novel  heterocycles.59  (Schemes 
2.0),  (Schemes 2.1),  (Schemes 2.2)                                                                                                                                   
Scheme 2.0. One-pot Synthesis of Pyarnobenzopyrans. 
 
              58                                                                                                   59 
R1 = 7-H, 7-OH, 6-Me 
Scheme 2.1. One-pot Synthesis of Amide Substituted Pyranobenzopyran. 
 
 
     60                                                                                                   61                            
   R1 = H, Me                                                                                             R4 = CONR2R3                                                          
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Scheme 2.2.  Efficient, Synthetic Protocol for Thia-Diazole. 
 
  
              62                                                                             63 
. R1 = 7-H,  7-OH, 6-Me                                                                  R4 = CONR2R3           
 
2.2.2. Synthesis of Pyranobenzopyran Derivatives as  Potent Antibacterial Agents 
Mulwad  and  his  group  reported  the  synthesis  of  pyranobenzopyran  derivatives  as  
a  potent  antibacterial  agents  by  using  3-formyl-4-hydroxy-2 H (1)-benzopyran-2-
ones (1a-d)  in  reactions  with  diethyl  malonate  in  the  presence  of  piperidine to 
give  ethyl-2 H,5 H-2,5-dioxopyrano[3,2- c ]  benzopyran-3-oate 2a-d..  Michael  addition  
of  (2a-d)  with  ethyl  acetoacetate  gives  ethyl  2,4-dihydroxy-5H, 12 H - 5, 12-dioxo  
[2]  benzo pyrano  [4,3-c ] [1]  benzopyran- 1-oate (3a-d).  on  Pechmann  condensation  
with  ethyl  acetoacetate  gives  2-acetyl-1,6-dihydroxy-3 H,  7H,14 H-3,7,14-trioxo-
pyrano [2 / ,3 / ,5,6]  [2]  benzo  pyrano  [3,2- c ]  benzopyran (4a-d). Michael  addition  
followed  by  cyclization of  acetylacetone  with  ethyl-2 H,  5H-2,5-dioxo-pyrano[3,2-c ]  
benzopyran-3-oate (2a-d)  in  the  presence  of  sodium  methoxide  in  boiling  
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methanol  afforded 1-acetyl-2-methyl-4H, 5 H,12 H, 4,5,12-trioxo-dipyranobenzopyran.60                 
(Scheme 2.3). 
Scheme 2.3. 1-acetyl-2-methyl-4H, 5 H,12 H, 4,5,12-trioxo-dipyranobenzopyran 
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2.2.3. Molecular Iodine-catalyzed Diastereoselective Synthesis of cis-Fused 
Pyranobenzopyrans and Furanobenzopyrans.                                                                    
Recently, molecular  iodine  has  received  considerable  attention  as  an  inexpensive  
and  readily  available  catalyst  for  various  organic  transformations  due  to  its  
moderate  Lewis  acidity  and  water  tolerance.  Jun  Wang,  and  his  group in  May  
2008  described  a  diastereoselective  synthesis  of  cis-fused  pyranobenzopyrans  
and  furanobenzopyrans  via  a  molecular  iodine-catalyzed  reaction  of                                   
o-hydroxybenzaldimines  with  3,4-dihydro-2H-pyran  and  2,3-dihydrofuran  at  ambient  
temperature. Using  this  method,  2-butoxy-4-N-arylaminobenzopyrans were  also 
synthesized  from  o-hydroxybenzaldimine  and  n-butyl  vinyl  ether. The  notable  
features  of  the  procedure  include  mild  and  metal-free  reaction  conditions, 
operational  simplicity,  using  a catalytic  amount  of  molecular  iodine  (2  mol %), 
short  reaction  time,  and  good  yields.61  (Scheme 2.4),  (Scheme 2.5),                                
Scheme 2.4.  Synthesis of Furanobenzopyrans. 
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Scheme 2.5.  Synthesis of Pyranobenzopyrans. 
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2.2.4. Diastereoselective, One-Pot Synthesis of  Pyranobenzopyran, 
Furanobenzopyrans  and  Tetrahydroquinolines  Derivatives.                                                    
The  classical  Diels-Alder  reaction,  a  [4+2]  cycloaddition  of  diene  and  dienophile  
to  generate  a  six  membered  carbocyclic  system  in  modified  form  can  be  used  to  
generate  nitrogen  or  oxygen  containing  six  membered  rings.  In  February  2004,  
Senthil  Kumar  and  his  group  reported  a one-pot   procedure  which  is  useful  when  
the  diene  is  unstable  and  difficult  to  purify  either  by  distillation  or  
chromatography. Lewis   acids  such  as  lanthanide  triflates,  were  found  to  catalyze  
this  reaction,  however  most  of  these  reactions  suffer  from  various  disadvantages  
such  as,  more  than  a stoichiometric  amount  of  catalyst  is  needed  due  to  strong  
coordination  of  it  with  the  heteroatoms,  longer  reaction  times,  higher  costs  and  
use  of  only  aprotic  solvents  under  anhydrous  conditions.  Also,  these  reactions  
cannot  be  performed  in  one  pot  because  the  amine  and  water  that  are  present 
during  the  formation  of  imine  can  decompose  or  deactivate  the  Lewis  acids. 
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However  the  use  of  KHSO4   as  a catalyst  is  inexpensive,  mild,  and  does  not  
require  the  maintenance  of  anhydrous  conditions. Treatment  of  salicylaldehyde,  
amine,  and  dihydropyran  in  the  presence  of  KHSO4   in  methanol  at  room  
temperature  gave  an  inseparable  mixture  of  linearly  cis- fused  pyranochromanees  
with  higher diasteroselectivity.62  (Scheme 2.6).                                                                                                                                
Scheme 2.6. One-Pot Synthesis of Furanobenzopyrans. 
71                          72              65                                            73                                    74                     
 
Scheme 2.7. One-Pot Synthesis of Pyranobenzopyran    
    
71                    72             68                                         75                               76 
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2.2.5. Diastereoselective   Synthesis  of  cis-fused  Pyrano-  and  Furanobenzopyrans 
Catalyzed  by  Indium  Trichloride  or  Triphenylphosphonium  Perchlorate                      
 In  October  2002,  Marimuthu  Anniyappan  and  his  research  group  reported  the  
application  of  Indium  trichloride  and  triphenylphosphonium  perchlorate  to  be  
effective  catalysts  for  the  cyclization  of  o-hydroxyaldimines  with  3,4-dihydro-2H-
pyran  and  2,3-dihydrofuran  at  ambient  temperatures  to  afford  novel  pyrano-  and  
furanobenzopyrans  and  their  derivatives  (Schemes 2.8 and 2.9). One  pot  syntheses  
of  pyrano-  and  furanobenzopyrans  from  o-hydroxybenzaldehyde,  aromatic  amines  
and  an  enol  ether  under  identical  conditions  was  reported  for  the  first  time 
(Scheme 2.10). Similarly, various  substituted  salicylaldimines  reacted  well  to  give  
the  corresponding  cis-fused  pyranobenzopyrans  in  good  yields.62                                                                                           
Scheme 2.8. Synthesis of Pyranobenzopyrans Using  Indium  Trichloride  and  
Triphenyl  Phosphonium Perchlorate   
  
   77                         68                                                   78                                           79 
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Scheme 2.9.  Synthesis of Furanobenzopyrans  Using  Indium  Trichloride  and  
Triphenyl  Phosphonium Perchlorate.                                                                                                                                                                                      
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Scheme2.10. One pot  Syntheses  of  Furanobenzopyrans  Using  Indium  Trichloride  
and  Triphenylphosphonium Perchlorate. 
71                                    65                                         80                                         81 
2.2.6. Sc(OTf)3  Catalyzed  Synthesis  of  Pyrano[3,2-b]-1-Benzopyrans  from  D-glycals                    
In  this  report, Yadav  and  his  research  group  had  describe  a new  and  efficient  
method  for  the  synthesis  of  fused  pyranobenzopyrans  from                                                  
o-hydroxybenzaldehydes  and  glycals  using  a  catalytic  amount  of  scandium  triflate. 
Thus  treatment  of  o-hydroxybenzaldehyde  with  3,4,6-tri-O-methyl-D-glucal  and  
trimethyl  orthoformate  (TMOF)  in  the  presence  of  3 mol%  of  Sc(OTf)3  in  
dichloromethane  at  ambient  temperature  resulted  in  the  formation  of  the cis-fused 
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pyrano[3,2-b]benzopyran  in  80%  yield  (Scheme 2.11). Similarly,  several 
salicylaldehydes  reacted  well  to  give  the  corresponding  cis-annelated   acetals  in  
excellent  yields. In  all  cases,  the  reactions  proceeded  smoothly  at  ambient  
temperature  with  high  selectivity. Only  one  diastereomer  was  obtained  in  each  
reaction,  the  structure  of  which  was  established  with  the  help  of  various  NMR  
experiments  like  double  quantum  filtered  correlation  spectroscopy,  nuclear  
Overhauser  effect  spectroscopy  and  selective  homonuclear  decoupling  studies.63  
Scheme 2.11. Synthesis of pyrano[3,2-b]-1-benzopyrans from D-glycals 
 
 
           82                      83                                                                 84 
2.2.7. LiBF4-Catalyzed Formation of  Fused  Pyrano-  and  Furanobenzopyrans 
 In  this  report,  Yadav  and  his  group  described  a  new  and  highly  efficient  
protocol  for  the  synthesis of  fused  pyrano- and  furanochromanes  (Scheme 2.12),  
(Scheme 2.13),  using  a catalytic  amount  of  LiBF4  in  acetonitrile. The  treatment  of  
the Schiff  base of  salicylaldehyde  with  2,3-dihydrofuran  in  the  presence  of  lithium  
tetrafluoroborate  at  ambient  temperature  afforded the  cis-fused  furanochromane  in  
90%  yield.  Similarly, several  o-hydroxybenzaldimines  (formed  in  situ  from                           
3 o-hydroxybenzaldehydes  and  anilines  in  the  presence  of  anhydrous  Na2SO4  in  
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acetonitrile)  reacted  well  to  give  the  corresponding  cis-fused  acetals  in  excellent  
yields. The  reactions  proceed  smoothly  at  ambient  temperatures  with  high  
diastereoselectivity.64 In  all  reactions,  the  product  was  obtained  as  a  single  
isomer, the  structure  of   which  was  confirmed  by  detailed 1H-NMR  and  NOESY  
experiments.                    
 Scheme 2.12. Synthesis of Furanobenzopyrans Using  a Catalytic  Amount  of  LiBF4.  
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Scheme 2.13. Synthesis of Pyranobenzopyrans Using  a Catalytic  Amount  of  LiBF4 
 
 
          85                        65                                         87                                      88 
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2.3. Glycals in Heterocyclic Organic  Synthesis.   
  Glycals  are  cyclic  vinyl  ether  derivatives  of  sugars  that  contain a  double  bond  
between  carbon  atoms 1  and  2  of  the  ring  These  1,2  unsaturated  sugars  89  are  
either  commercially-available  or  easily  prepared  from  1-halogeno  sugars.  
Manipulations  of  this  double  bond  have  been  the  focal  point  of  many  syntheses  
that  use  glycals  as  starting  materials. Addition   reactions  have  been  employed  in  
the  preparation  of  carbohydrate-based  compounds,  including  fused  heterocycles.  
A survey  of  the  current  scientific  strategies  may  prove  useful  when  applied  to  
sugars  with  double  bonds   at  other  position  of  the  molecule.65                           
 Figure 2.1. 1, 2- Unsaturated Sugars  (glycals) 
                             
                                            89 
  2.3.1.  Hybrids  of  Sugars  and  Aromatics:  A Pd-Catalyzed  Modular  Approach  to 
Chromanes  and  Isochromanes.                                                                                                  
Markus  Leibeling  and  his  group  reported  the  synthesis  of  chromanes  and  
isochromanes  using  carbohydrates  as  starting  materials. They  report  the  full  
details  of  this  highly  efficient  procedure  to  access  chromanes  and  isochromanes  
by   utilizing   an  appropriately  substituted  2-bromoglycal  as  the starting  material  of  
a  domino  reaction  (Scheme 2.14).66  Their  method  allowed  for  the  easy 
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introduction  of  defined  stereocenters  on  the  pyran  unit. For  the  creation  of  the  
benzene  moiety  an  intramolecular  Pd-catalyzed reaction was  used   that  employs  a  
diyne  chain  attached  to  the  pyran  core. Such  a  procedure  allows  the  synthesis  
of  heavily  functionalized  chromane  and  isochromane  derivatives  that  are  difficult  
to  obtain  by  other  routes. The  target  molecules  may  be  regarded  as  hybrids  
between  carbohydrates  and   an aromatic  compound. 
Scheme 2.14. Synthesis of  chromanes  and  isochromanes 
 
Chromane                                                                                       Isochromane 
                                                       
                    89                                                                                              90 
                                    
                                                            
                  91                                                                                                    92 
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2.2.2. The hetero Diels-Alder approach to  carbohydrate-containing  molecular  
scaffolds 
Martina  Cacciarini  and  her  group  at the University  of  Florence  used a  strategy  
that   relies on  a  totally  steroselective  hetero  Diels-Alder  reaction. It  is  an  inverse  
electron-demand  [4+2]  cycloaddition  between  α,α’ –dioxo-thiones,  α-oxo- α’-
iminothiones  or  ortho-thioquinones   as  electron-poor  heterodienes  and  unprotected  
or  differently  protected  glycals  as  electron-rich  dienophiles.67 (Scheme 2.14).                   
Scheme 2.16. Carbohydrate-Containing Molecular Scaffolding. 
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The research group of Professor   Marzabadi became interested in developing a   
general  method  for  the  synthesis  of carbohydrate-based  oxazolines  accessed  from   
2-iodo-glycosylamides,68  Glycosylamides  were  prepared  by  reaction  of  
different  protected  glycals  with  N-iodosuccinimide  and  alkyl  and  aryl  amides.   
Mixtures of diastereomers were obtained from these reactions. These were then 
cyclized in the presence of base to produce the heterocycle.  Assignment of the   
product  stereochemistry  was  made  by  analyzing  the  vicinal  coupling  constants  in 
the product’s  NMR  spectra  (Scheme 2.16) 
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 Scheme 2.17. Synthesis of  Glycosylamides.  
 
 
97                                                                      98                                                          99 
Professor  Marzabadi  has  also  focused  in  the  preparation  of  C-linked, quinoline 
derivatives  from  glycals. They  developed  and  expanded  the  scope  of  a  facile, 
one- pot  method  based  upon  Povarov  reaction  to  prepare  novel  C-glycoslated  
quinolines. The  reaction  proceeded  through  the  stereoselective  formation  of  sugar-
spiroanellated  tetrahyroquinoline  intermediates69. These  compounds  are  
subsequently  oxidized  and  undergo  sugar  ring  opening   to  form  the  fully  
aromatized  quinolines  (Scheme  2.18).                                                                          
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Scheme 2.18.  Synthesis of Spiroanellated  Tetrahyroquinoline  
 
2.4 Summary                                                                                                                                 
Pyranobenzopyrans  and  their  derivatives  are  oxygen  heterocyclic  compounds  that  
structurally  consist  of   a pyran  ring  fused  to  chromane  or  chromene  and/or  their  
derivative. The  synthesis  of  pyranobenzopyrans  and  their  derivatives  has  been a  
subject  of  great  importance  in  the  field  of  organic  chemistry  because  of  the  
biological  activity  of  naturally- occurring  representatives.                                                                                                 
In  our  survey  of  the  literature, many  research   groups  synthesized  
pyranobenzopyrans  and  their  derivatives  in  different  ways  by  using a  variety  of  
starting  materials,  but  there  is  only  one  report  on  the  synthesis  of  
pyranobenzopyrans  from  using  unsaturated  carbohydrates  (glycals)   in  place  of   
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3,4-dihydro-2H-pyran. This reaction was reported by Yadav and  his  colleagues.                        
We  report  additional  studies  directed  at  the  synthesis  of  these  molecules.                                                       
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Chapter 3 
 
The Synthesis of Carbohydrate-Fused  Benzopyrans 
 
3. Results 
3.1. Synthesis of the Starting Materials.                                                                                       
Due  to  the  growing  interest  in  carbohydrate  drugs  and  the  importance  of  the  
pyranobenzopyran  moiety,  as  mentioned  before,  we  focused  our  efforts  on  doing  
synthesis  in  this  area  and  in  the  development  of  convenient  methods  for  doing 
this  chemistry  using  glycals  as  precursors.  We  first  needed  to  prepare  the  
starting  materials  from  which  we  would  conduct  our  research. The  synthesis  was  
begun  with  the ester  hydrolysis  of  commercially-available  tri-O-acetyl-D-glucal 105  
to  produce  D-glucal  106  (Scheme  3.0).70  This  material  is  used  as  a starting  
material  for  preparation  of   tri-O-benzyl-D-glucal  97  and  tris-O-t-butyl-dimethylsilyl-
D-glucal  107  using  published  literature   procedures71  (scheme 3.1)  and  (Scheme 
3.2).  The  idea  behind  the  use  of  the  different  protecting  groups  was to  study  the  
effect  of  the  protecting  group  on stereoselectivity  and  the  two  different  groups  
activate  the  double  bond  to  cycloaddition  during  the  synthesis  of  
pyranobenzopyran. The imine 108   was also prepared   using known literature 
procedures. The  synthetic  procedure  involved  a  room  temperature  reaction   
between  2-hydroxybenzaldehyde  and  aniline.  (Scheme 3.4).                                                                                                                                   
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Scheme 3.0 De-O-acetylation of  D-Glucal 
 
 
                   105                                                             106 
 
Scheme 3.1. Benzylation 
 
                106                                                         97                        
 
Scheme 3.2. Silylation 
 
                 106                                                                     107 
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Scheme 3.3. Synthesis of the Imine 
  
     71                              72                              108 
3.2. Catalyst   Screening 
  In  order  to  investigate  conditions  for  the  cycloaddition  reaction  between  the  
glucal  and   benzaniline,  we  screened  several  rare  earth  metal  triflates  as  Lewis  
acid  catalysts  (Table 3.0).  Based  on  our  literature  survey,68  we  chose  to  study  
Sc(OTf)3,  InCl3,  Yb(OTf)3,  PdCl2   and  TESOTf  as  they  had  shown  effectiveness  
in  other  similar  reactions.                                                                                                       
3.3. General Synthetic Procedure. 
Despite  the  multitude  of  publications  covering  the  synthesis  of  
pyranobenzopyrans,  we  focused  our  work  on  using  a less  common  method  for  
synthesis. Our reactions  utilize  an  inverse electron- demand Diels-Alder reaction. This 
is  a [4 + 2]  cycloaddition  of  a diene  and  a dienophile  to  generate  a  six- membered  
heterocyclic  system; 63  in  our  case  an  oxygen  containing  six-membered  ring  
system. We  tried  three  different  methods  for  carrying  out  these  reactions   using  
glycals 106  as  both  the  dienophile  and  the heterodiene. The  different  methods  
used  are  listed  below  as  are  the  different  conditions  of  temperature,  catalyst,  
reaction  time  and  solvent  (See Tables. 3.1, 3.2, 3.10 and 3.11 ).                                                                   
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3.3.1. The Conventional  Cycloaddition  Methods.                                                                                                                                                                                                                                
In  this  method,  we  used  a  known  procedure  from  the  literature  in  which   a 
variety  of  protected  glucals:   tri-O- acetyl-D-glucal 105,  tri-O- benzyl-D-glucal 97  and  
tris-O-tert-butyldimethlsilyl-D-glucal 107  (scheme 3.4)73  were  reacted  with  imine  108  
in  the  presence  of  a catalyst  in  organic  solvent. The  effects  of  the  alcohol  
protecting  group,  solvents  and  catalysts  on  the  reactions  rates,  the  product  
yields,  and  the  product  stereoselectivities  of  the  addition  reaction  were  studied 
(Table 3.1). The  choice  of  the  solvents  used  was  based  upon the  substrates  and  
catalysts  being  readily  soluble  in  dichloromethene  and  acetonitrile. The  reactions  
were  conducted  under  nitrogen  and  a range  of  temperatures  were  applied.    
Scheme 3.4. Conventional Methods. 
                                                                                                                                                                                                                                     
 
   108                                       89                                            109 
 R = Bn, Ac, TBDMS,  Solvent = CH3CN, CH2Cl2,    Catalyst = Sc(OTf)3,  InCl3,  Yb(OTf)3,  PdCl3  and  
TESOTf 
3. 3.1.1. Reaction Mechanism 
The  postulated  reaction  mechanism   for  the  synthesis  of   pyranobenzopyrans  is  
as  follows  (Scheme 3.5): first,  the  Lewis  acid  catalyst  complexes  to  the  nitrogen  
of  the  imine 109   resulting  in  the  formation  of  the  iminium  ion  intermediate 110  in  
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which  the  nitrogen  atom   bears  a  positive  charge. The resulting o-quinonemethide    
acts as an oxadiene 111. The  electrons  from  the  activated  alkene  react  with  the  
unsaturated  sugar  to  create  a  bond  that  couples  the  two  compounds  together  to  
give  the  pyranobenzopyran 112. 
 Scheme .3.5. Reaction Mechanism for the Synthesis of  Pyranobenzopyrans  
  
        
    108                                   110                      111                  89                                 109    
      R = Bn, Ac, TBDMS 
    
From  our  observations,  the   reactions  of  tri-O-acetyl-D-glycal  105  took  a long  time  
and  did  not  progress  with  different  solvents  and  different  catalysts  even  after 7 
days  (Table 1).  That  is  most likely  due  to  the  deactivating  nature of  the   electron  
withdrawing  acetate  groups  in compound 105.  In  the  cycloaddition  reaction,  
electrons  of  the  π-system  of  the  sugar  must  be  available  for  bonding  to  occur,  
therefore;  having  electron  withdrawing  protecting  groups  will  decrease  the  electron  
density  of  the  double  bond  and  slow  down  the  reaction. On  the  other  hand,  with   
tri–O-benzyl-D-glucal 97,  the  benzyl  group  is  electron  donating  and  we  postulated  
that  the  reaction  would   work  better.  However,  the  same  results  were  obtained  
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with  this  protecting  group  when  the  reactions  were  conducted  at  room  
temperature.  When  the  experiments  were  conducted  at  60  and  80 0C,  we  
observed  a  gradual  color  change  from  yellow  to  brown. The   progress  of  the  
reaction  was  checked  by  TLC  (90:10 hexane/ethyl acetate)  and a  mixture  of   
products  were  observed  along  with  a large  amount  of  unreacted  starting  material. 
These  results  can  be  explained  by  the  effect   of  the  benzyl and silyl  protecting  
groups that  causes  steric-hindrance  for  the  reaction  and  hinders  its  progress, 
where acetyl glucal has electron  withdrawing  nature  will decrease the  electron 
density of the double bond and hence slow down the rate of  the  reaction.    
 3.3.1.2. Summary.                                                                                                                                       
The synthesis of  pyranbenzopyrans  using  the  conventional  method  was  
unsuccessful. That  may  be  due to   many  factors  including: the  effect  of   the  size  
and  the  nature  of  the  protecting  groups  that  can  block  or  electronically  
deactivate  the  glycal  double  bond  in the  Diels-Alder  reaction.                                                                                                           
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Table 3.1. The Conventional Methods and conditions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dienophile Temp 0C Time Catalyst Solvent 
Tri-O-acetyl-D-
glucal 
25 7 days  Sc(OTf)3 CH3CN  
 
25 7 days InCl3 CH2Cl2 
Tris-O-tert-
butyldimethylsilyl-
D-glucal 
25 7 days  Sc(OTf)3 CH3CN 
 
25 7 days InCl3 CH2Cl2 
Tri-O-benzyl-D-
glucal 
25 7 days Sc(OTf)3 CH3CN  
                25 7 days InCl3 CH2Cl2 
 
25 7 days PdCl2 CH3CN 
 
25 7 days Yb(OTf)3 CH3CN 
 
25 4 days TESOTf CH3CN  
 
60 18 hr Sc(OTf)3 CH3CN 
 
60 18 hr TESOTf CH3CN 
 
80 18 hr Sc(OTf)3 CH3CN 
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 3.3.2. The Microwave Reactor.                                                                                                                         
Our  failure   in  obtaining   pyranobenzopyrans  using  the  conventional  synthetic 
method  led  us  to  think  about  other  possible  procedures.  Because  the  Diels-Alder  
reaction   requires  higher  energy  to  take  place,74  we  chose  microwave  activation  
as  a non-conventional  energy  source. Microwave  energy  has  become  a very    
popular  and  useful   technology   in  organic  chemistry. The  conventional  heating  
techniques  such  as  a hot  plate,  oil  bath,  heated  jackets  and  sand  baths,  are  
rather  slow  and a temperature  gradient  can  develop   within  the  sample. In  
addition,  local  overheating  may  lead  to  decomposition  of  reactants  as  well  as  the  
products. On  the  other  hand,  microwave  radiation  passes  through  the  walls  of  
the  reaction  vessel  and   heats  only  the  reactant  and  solvent. The  heating  effect  
utilized  in  microwave- assisted  organic  transformations  is  due  to  dielectrical  
polarization,  although  conduction  losses  can  also  be  important  particularly  at  
higher  temperatures.72  Only  dipolar  and  interfacial  polarization  are  important  
factors  in  heating  effects  associated  with  microwave  irradiation, the  use  of  polar  
components  facilitates  the  absorption  of  microwave  energy  and  consequently  the  
conversion  into  heat  and  with  the  use  of  a  sealed  vessel  it  was  possible  to  
increase  the  temperature  and  eventually  the  pressure  and  the  reaction  rates.75 
The  short  reaction  times  and  expanded   reaction  range  offered  by  microwave  
assisted  organic  syntheses  are  suited  to  the  increased  demand  of  the  chemical  
industry. “It  is  nearly a  Herculean  effort  to  give  a  complete  overview  where  
microwave  heating  has  been  applied  to  heat  up  chemical  reactions.” 76-86   
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“Even  below  room  temperature  microwave  irradiation  is  used  to  run  reactions  in  
combination  with  simultaneous  cooling.” 87, 88     
3.3.2.1. The Background of the Microwave   Technology.                                                                 
Diels‐Alder Reactions   
  In  1986  several  Diels‐Alder  reactions  were  investigated  in  the  microwave  oven.  
For example,  the   reaction  of  anthracene 113  with  maleic 114  anhydride  provided  
the  required  product  yield  in 89%   in  5  minutes .89  (Scheme 3.6). 
   Scheme 3.6.  Diels‐Alder Reaction of Anthracene with Maleic  Anhydride. 
   
    113                                       114                                      115 
In  our  survey  of  the  literature  the  use  of  microwave  energy  in  carbohydrate  
chemistry  is  very  limited, we  reviewed  the  application  of  microwave  reactors  in  
carbohydrate   chemistry;  below are  some examples: 
Peracetylation                                                                                                                                    
Peracetylation 117  of  D-glucose 116 to  give  the  penta-O-acetyl  derivative  with  a 
small  excess  of  acetic anhydride  under  catalysis  with  either  anhydrous  potassium  
or  sodium  acetate  was  carried  out  and  the  reaction  reached   completion  within  
15  minutes  in  the  microwave  reactor.90  (Scheme  3.7) 
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Scheme 3.7 Peracetylation 
 
 
                116                                                        117 
              Catalyst = anhydrous potassium  or  sodium  acetate 
Benzoylation.                                                                                                                            
In  order  to  verify  the  possibility  of  modulating  the  selectivity  in  microwave-
promoted  protection  of  hydroxyl  functionalities, Herradòn et  al.91  studied  the  
influences  of  both  the  solvent  and  the  power  output  of  the  oven  on  the  
selectivity  of  dibutylstannylene  acetal-mediated  benzoylation   of  methyl α-D-
mannopyranoside  118  with  PhCOCl,  n-Bu2SnO  and  Et3N, the  resulting  compounds 
119, 120  and  120  shown  in  (Scheme 3.8)  “ verify  the  possibility  of  modulating   
the  selectivity  in  microwave-promoted  production  of  hydroxyl  functionalities.” 91  
Scheme 3.8. Benzoylation 
    
118                                              119                               120                                120 
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Acetal Formation. 
This  method,  was  modified  by  Oscarson  when  he   treated  α-D-glucopyranoside  
121 with   benzal  bromide  and  N-(methylpolystyrene-4-(methylamino)pyridine  in  
acetonitrile  to form  4,6-O-benzylidene  derivative 122  at 170°C  for  5  min  to  yield  
83%  of  the  product  (Scheme 3.10).92 
Scheme 3.9. Acetal Formation. 
 
 
                   121                                                                 122 
Pterins. 
Isay   condensed   pyrimidine diamine  123  with  aldohexoses,  to  afford  pterins  with  
a  sugar  substituent   (Scheme 3.10)  under  microwave  irradiation  (300 W)  for  270  
sec. Interestingly,  the  desired,  isomerically  free,  6-substituted  sugar  derivatives  
were  synthesized  in  moderate  to  good  yields,  whereas  mixtures  of  two  isomers  
are  generally  obtained  using  conventional  Isay  type  condensations.93   When  
benzene  diamine,  was  used,  quinoxaline  124  was  obtained.   (Scheme 3.11).   
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Scheme 3.10. Synthesis of Pterins. 
 
 
            123                                         124 
            R = R’= H                                  R =R’ = Ac 
 
Scheme 3.11. Synthesis of Quinoxaline 
 
 
       125                                                        126 
3.3.2.2. Microwave Reaction Results 
The  variety  of  applications  of  microwave technology in  carbohydrate  chemistry  
especially  in  the  field  of  synthesis  and  the  high  yields  obtained  in  short  reaction 
times,  encouraged  us  to  use    microwave   irradiation  in  synthesis  of   
pyranobenzopyrans. Since  the  conventional  methods  failed  to  produce  our  target  
molecules,  we  used  the  same  procedure  that  we  applied   in  the  conventional  
method  to see  if  there  would  be an improvement,  (Scheme  3.12)   The  only  
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difference  was  the  total  volume  of  the  reactant   mixture used  was  7 mL  and  that  
was  based on  the  microwave  tube  volume. Different solvents and different conditions 
were used  also (Table 2). The  temperature  and  the  pressure  were   adjusted  
according  to  the  boiling  point  of  the  solvent. Solvents  play  an  important  role  in  
organic  synthesis  and  microwave heating,  therefore  the  choice  of  the  solvent  can  
be a crucial  factor  in  the  outcome  of  a  reaction  in  microwave  reactor. One of the 
important characteristics of the solvent is its polarity.  With  microwave  heating,  this  
becomes  a more  significant  component,  as  microwaves  directly  couple  with  
molecules  that  are  present  in  the  reaction  mixture. This  interaction  leads  a  rapid  
rise  in  temperature  and  faster   reaction  rates.                                                                                                                   
 Scheme 3.12. Synthesis of Pyranobenzopyrans Using a Microwave. 
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Table 3.2. Microwave conditions 
Dienophile Solvent catalyst Temp 0C Pressure 
Bar 
Power  W Time min 
Tri-O-acetyl-D-
glucal 
DCM TESOTF 65 6 300 20 
DCM Sc(OTf)3 65 6 300 20 
Acetonitrile TESOTF 82 10 300 20 
Acetonitrile Sc(OTf)3 82 10 300 20 
Tri-O-benzyl-D-
glcual 
Acetonitrile TESOTF 82 10 300 20 
Acetonitrile Sc(OTf)3 82 10 300 20 
Acetonitrile TESOTF 82 10 300 20 
Acetonitrile Sc(OTf)3 82 10 300 20 
Tris-O-tert-
butyldimethylsilyl-
D-glucal 
Acetonitrile TESOTF 82 10 300 20 
Acetonitrile Sc(OTf)3 82 10 300 20 
 
The  results  in (Table  3.2)  show  the  different  conditions  that  we  used  for  the 
microwave  reactor.  We  used  dichloromethane  and  acetonitrile  as  solvents  
because  all  the  reactants  are  soluble  in  them. The  boiling  point of 
dichloromethane  is  very  low  (40 0C)  and  the maximum  temperature  we  could  
apply  for  the  reaction  was  65 0C.84  The  time  was  increased  gradually  from  5  
minutes  to  20  minutes  and  the  progress  of  the  reaction  was  checked  by  TLC  
every  two  minutes. The  reaction  color  gradually  changed  from  yellow  to  brown  
and  when  the  time  reached  20  minute  the  color  had  turned  black,  and  when  we  
checked  by  TLC decomposition  of  the  imine   was  observed. The  use  of  
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acetonitrile  as  a  solvent  with  tri-O-acetyl-D-glucal  and  tris-O-tert-butyldmethylsilyl-
D-glucal  did   not   enhance  the  conversion  and  with  an  increase  in  the  reaction  
time  and/or  the  the  reaction  temperature  decomposition  of  the  imine  was  
observed. When  acetonitrile  was  used   as  a  solvent  with  tri-O-benzyl-D-glucal  at  
a  temperature of  82 0C  for  16  minutes,  only  a  small  amount  of  product  formation  
was  observed  by  TLC. This  was  a mixture  of  products  that  were   difficult  to  be   
isolated  and  identify,  with  an  increase  in  time  and/or  temperature,  the  products  
and  starting  imine  were  shown  to  have  decomposed.  Because  we  were  
unsuccessful   in  producing  our  target  molecule  using  this  method,  we  thought  
about  a  one  pot  synthesis,  in  which   the  production  of  fresh  imine  in  the  
microwave  reactor  may  help  the  reaction  to  move  forward  and  lead  to  the  
formation  of  the  target  product  (Scheme 3.14). The  reaction  was  setup  by  mixing  
tri-O-benzy-D-glucal 97, o-hydroxybenzaldehyde 71,  and  aniline 72,  in  acetonitrile  
was  catalyzed  by  scandium  triflate (5 mole %).  Different temperature ranges  and  
times  were  applied.  Unfortunately  the  TLC  showed  only  the  starting  material, after  
18  minutes  and  this  method  was  abandoned.                                                                               
 Scheme 3.13. The Microwave Reactor in One Pot Synthesis.       
  
      71               72             97                                                     127      
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3.3.2.3.Summary                                                                                                                                                                                                                                                        
We  hypothesized  that  since  microwaves  are  powerful,  reliable  energy  sources  in  
which  the  microwaves  couple  directly  with  molecules  that  are  present  in  the  
reaction  mixture, that  this  rapid  rise  in  temperature   may  promote  our  reaction  
towards  the  formation  of  the  required  product  and  thereby  increase  the  yield. 
Unfortunately  no  reaction  took  place  with  the  various  microwave  conditions.       
The reasons  for  failure  to  react  may  be  due to  the  presence  of  large protecting  
groups  as  previously  discussed  or to  the  effect  of  their  electron  withdrawing  
nature. Although  many  attempt  to  synthesize  this  molecule  were  made  by  using  
the  microwave  reactor, unfortunately  we  were  unsuccessful. Then we decided to  try   
non-traditional  solvents, the  ionic  liquids. These  solvents  possess  many  good  
chemical  and  physical  properties  and  it  was  our  hope  that  they  would  enable  
the  synthesis of  our  target  molecules.   
3.3.3.The  Use  of  Ionic  Liquids  as  Solvent  in   the  Synthesis  of  Pyranobenzopyran                                                                                                                                  
3.3.3.1. Ionic Liquids- an Overview.                                                                                            
Ionic  liquids  (ILs)  are  organic  salts  that  are  liquid  at  ambient  temperature. They   
consist  of  organic  cations  such  as: imidazolium,  pyridinium,  sulfonium,  
phosphonium, etc. (Figure 3.0)   and  organic  or  inorganic  anions  (Figure 3.1).94  Ionic  
liquids  have  emerged  as  a new  class  of  solvents  that  can  be  used  as  an  
alternative  to  environmentally- volatile  organic  solvents. They  are practical  
alternatives, due  to  their  unique  combination  of  low  volatility, low  melting  point, 
chemical  stability, high  conductivity, wide  electrochemical  window, and  their  ability  
to  dissolve  organic  and  inorganic  solutes  and  gases. 95-99  
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  Figure 3.0. The Most Common Ionic Liquid Cations. 
                                                         
   Imidazolium                    Pyridinium                 Thiazolium                           Lithium 
Figure 3.1. The Most Common Anions 
[BF4]-                                [PF6]-                              [OTf]-                          [Al2Cl7]-
Tetrafluoroborate        Hexafluorophosphate          Triflate                   Aluminium chloride 
Ionic  liquids  are   not   easily  crystallized  and  remain  liquids  through  a wide  range  
of  temperatures. They  are  not  often  involved  in  the  processes  of  solvolysis  and  
solvation, usually  associated  with  traditional aqueous  and  organic  solvents,  and   
can  also  be  designed  to  solubilize  either  polar  or   non-polar  molecules. Hence,  
ionic  liquids  are  attracting  attention  as  potential  replacements  for  the  
conventional,  volatile,  environmentally  harmful  organic solvents.    
The  particular  importance  of  the  ionic  liquids: ability  to  Design  Specific  Physical  
and  Chemical  Properties. 
Arguably  the  most  useful  property of  the  ionic  liquids  is  the  ability  to ‘design’  or  
‘tune’ a  set  of  specific  desirable  physical  and  chemical  properties  through  the  
simple  adjustment  of  the  side  chains  of  the  cation  (R groups)  (Figure 2)  and / or  
the  appropriate  selection  of  the  anion  (Figure 3.0).100  The  range  of  physical  and  
chemical  properties  available  with  ionic  liquids  is  considerably  wider  than  those  
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of  commonly  used  organic  solvents. Thus, an  appropriate “Task  Specific  Ionic  
Liquid  (TSIL)” 100  can  be  designed  with  the  precise  physical  and  chemical  
properties  desired  by  the  end  user.;                                                                                                                                   
Low or Near Zero Vapor Pressure.                                                                                                                                                                                                                           
ionic  liquids are  salts, and  hence,  have  a very  low  or  a  nearly  zero  vapor  
pressure. Because  of  this  property  very  little  ionic  liquid   is  lost   into  the  
environment  through  evaporation, even  when  ILs  are  used  at  elevated  
temperatures  as  solvents  and /or  as catalysts;100                                                                                                                                                     
Low Melting Points.                                                                                                                   
Most  of  the  room  temperature  ionic  liquids   have  a  very  low  melting  point,  
enabling  them  to  be  liquids  at  or  below  room  temperature. This  low  melting  point  
can  be  attributed  to  the  asymmetric  nature  of  the  ions  making  up  these  salts. 
This asymmetry prevents the compact packing of the ions. The  ionic  liquid,                    
1-ethyl, 3-methyl  imidazolium  tetrachloraluminate  for  example  has  a melting  point  
of  9 0C;101                                                                                                                              
Water  Miscibility.                                                                                                                                                                                                                                                                      
Some ionic liquids are water miscible and  some  are  not. This  property  can  be  
switched  on  and  off  according  to  the  process  requirements  by  modifying  the  
cationic  structure  of  the  ionic  liquids  or  by  changing  its  anion. The  anion  chosen  
plays  a prominent  role  in  ionic  liquid  water  miscibility. [PF6]-,  (CF3SO2)2N]-  are  
example  of   water  immiscible  anions,  where  [CH3COO]-,  [CF3COO]-,  [NO3]-,  
[CH3CH2SO3]-, Br-,  I-,  and  Cl-  are  water  miscible  anions;101 
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Recoverability and Reusability.                                                                                                                                                                                                                                   
Since  the  miscibility  properties  differ  significantly  based  on  ionic  liquid  structure,  
the  products  of reactions  can  often  be  recovered  from  ionic  liquids  by  means  of  
extraction. Supercritical  CO2,  water  or  organic  solvents  can  be  used  to  recover  
products  and  enable  the  recycling  of  the ionic  liquid  for  subsequent  reactions;.                                                     
Large Liquid Range and Thermal Stability.                                                                      
Ionic  liquids  have  a very  large  liquids  range,  and  they  are  very  stable  with  
respect  to elevated  temperatures. For  example, 1-ethyl-3-methyl  imidazolium  
bis(trifloromethylsulfonyl)  imide  has  a  liquid  range  of  471  degrees,  with  a  melting  
point  15 0C  and  a  decomposition  temperature  at  455  0C.102  This  property  makes  
RTILs  useful  for  reactions  that  need  to  be  maintained  at  either  low  or  high  
temperatures. 
Air and Moisture Stable Ionic Liquids.                                                                                    
One  of  the  major  drawbacks  which  hinders  the  use  of  chloroaluminate  ionic  
liquids  is  their  sensitivity  to  air  and  moisture. The  development  of  ionic  liquids  
that  are  air  and  moisture  stable  has  provided  renewed  interest  in  ionic  liquid  
chemistry. The  concept  of  ionic  liquids  received  a  substantial  boost  by  the  Wilkes  
group  when  they  described  in 1992  the  synthesis  of  ionic  liquids  with  significantly  
enhanced  stability  against  hydrolysis;103,105                                                                                      
Acid-Base Properties  and  Water  Interactions.                                                                       
While  simple  salts  such  as  KCl  can  be  thought  of  as  the  product  of  an  electron  
transfer  between  elements,  organic  salts  can  be  traced  to  a proton  transfer  
between  an  acid  and  base. Cations  such  as  emim+  and  n-bupy+  result  from  the  
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alkylation  of  the  bases  emim+  and  py+.  Anions  such  as  [NO3]-,  [AlCl4]-   and                   
[PF]6-   derive  from  Lewis  acid  base  reactions. It  is  also  possible  for  Lewis  neutral  
ions  to  add  further  Lewis  acids  to  form acidic  ions, e.g., [Al2Cl7]-.  As  a  result  we  
can  obtain  Lewis  basic,  neutral  or  acidic  ionic  liquids,  exemplified  by  the  well-
researched  haloaluminates. In  addition  we  can  make  protic  acidic  liquids  which  
are  simultaneously  of  any  Lewis  aspect,106  and  relate the proton  chemistry  in  
ionic  liquids to  proton  chemistry  in  water. The  acidic  protons  in  ionic  liquids  are  
bonded  to  bases  such  as pyridine  and  ethylimidazole  are  not  labile,107  These  
bases  do  not  behave  in  line  with  their  pKb’s  in  water;  bases  in  ionic  liquids  
appear  to  act  in  accordance  with  their  gas  phase  proton  affinities                                                          
(l-methylimidazole > pyridine > ammonia).108  The  complicating  factor is  solvation  in  
water.  One  can,  however,  obtain  Hammett  acidity  data  for  some  systems  which  
make  fair  chemical  sense;109                                                                                           
Densities.                                                                                                                                     
The  density  range  of  ionic  liquids  is 1.1 to 1.6 g/cm-3,  and  it  mainly  depends  on  
the  type  of  cation  and  anion  used  in  the  IL. The  density  of  the  ionic  liquids   
depends on  the   bulkiness  of   the  organic  cation, with  an  increase  of  the  
bulkiness  of  the  cation  the  density  is  decreased. This  allows  the  chemist  to  
adjust  the  density  as  required  for  a  specific  synthesis (Table 3. 3).110                                                                                                                                   
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Table 3.3.  Densities of Imidazolium Ionic Liquids. 
 Ionic Liquid Density(g/cm-3) 
1 [bmim]BF4 1.320 
2 [bmim]PF6 1. 38 
3 [emim]PF6 1.426 
4 [emim]Br 1.575 
5 [emim]EtSO4 1.240 
 
Viscosity.                                                                                                                                
The  viscosity  of  an  ionic  liquid  is  essentially  determined  by  its tendency  to  form  
hydrogen  bonds  and  by  the  strength  of  its Van  der  Waals forces.110  Comparison  
of  the  viscosity of  different  hydrophobic  ionic  liquids  with  [bmim]+   ions  
emphasizes  the  interplay  between  Van der  Waals  interactions  and  hydrogen  
bonding  as  the  structure  of  the  cation  influences  the  viscosity. Low  viscosities  are  
usually  obtained  with  [emim]+  ion  in  which  a  mobile  side  chain  is  combined  with  
a  low  molar  mass.  Longer  or  fluorinated  alkyl  chains  result  in  higher  viscosities  
because  of  stronger  Van  der  Waals   interactions.111   
 3.3.2. Synthesis  of  Ionic  Liquids                                                                                                                                                                                                                                                                    
The  story  of  ionic  liquids  is  generally  regarded  as  beginning  with  the  first  report  
of  the  preparation  of  ethylammonium  nitrate  in 1914.  This  species  was  formed  by  
the  addition  of  concentrated  nitric  acid  to  ethylamine,  after  which  water  was  
removed  by  distillation  to  give  the  pure  salt,  which  was  liquid  at  room  
temperature. The  protonation  of  suitable  starting  materials  (generally  amines  and  
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phosphines)  still  represents  the  simplest  method  for  the  formation  of  such  
materials,  but  unfortunately  it  can  only  be  used  for  a  small  range  of  useful  salts. 
The  possibility  of  decomposition  through  deprotonation  has  severely  limited  the  
use  of   such  salts, and  so  more  complex  methods  are  generally  required.  
Probably  the  most  widely  used  salt  of  this  type  is  pyridinium  hydrochloride, Thus,  
most  ionic  liquids  are  formed  from  cations  that  do  not  contain  acidic  protons. 
The  majority  of  ionic  liquid  chemistry  based  on  nitrogen-containing  heterocycles  
focuses  on  the  use  of 1-alkyl- 3-methylimidazolium  and  N-alkylpyridinium  cations. 
1-Alkyl- 3-methylimidazolium  hexafluorophosphate  (AMImPF6), 1-alkyl-3-
methylimidazolium  tetrafluoroborate  (AMImBF4),  N-alkylpyridinium  tetrafluoroborate 
(APyBF4)  and  N-alkylpyridinium  hexafluorophosphate  (APyPF6)  are  typically  ionic  
liquids  used  as  solvent  or  catalysts. There  are  two  basic  methods  for  the  
preparation  of  these  ionic  liquids: metathesis  of  a  halide  salt  (Finkelstein step)  
with  silver,  group1  metal  or  ammonium  salt  of  the  desired  anion  and  acid–base  
neutralization   reactions. Either  way, there  is  a need  to  prepare  the  imidazolium  or  
pyridinium  halides  via  alkylation  (Menschutkin step)  using  a  large  molar  excess  of  
haloalkane  (10–400%)  for  as  long  as  72 h  at  refluxing  condition,  and  then  RTILs 
are  prepared  with  variable  yields  and  much  longer  reaction  times. The  most  
common  method  uses  stoichiometric  amounts  of 1-methylimidazole  or  pyridine,  
alkylhalides  and  the  potassium,  sodium  or  ammonium  salt  of  hexafluorophosphate  
or  tetrafluoroborate  in  one-pot  under  solvent-free  condition.112  (Scheme 3.14). 
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Scheme 3.14.  Synthesis of Imidazolium Ionic Liquid 
 
 
  3.3.3. Ionic  Liquids  as  Solvents:                                                                                                
In  recent  years,  environmentally-friendly  reaction  processes  have  been  extensively 
studied  from  the  standpoint  of  green  chemistry. For  example,  oxidation  reactions  
with    air,  or  reactions  in  water,  supercritical  fluids,  and  fluorous  solvents  are  
reported.  Most  recently,  ionic  liquids  have  gained  much  attention  as  green  
reaction  solvents  for  organic  synthesis.  As  seen  above,  ionic  liquids  are  salts,  
consisting  of  cations  such  as  imidazolium,  pyridinium, quaternary  ammonium  and  
quaternary  phosphonium, and  anions  such  as  halogen,  triflate,  tetrafluoroborate  
and  hexafluorophosphate, which  exist  in  the  liquid  state  at  relatively  low  
temperatures. Their  characteristic  features  include  almost  no  vapor  pressure, non-
flammability, non-combustibility, high  thermal  stability,  relatively  low  viscosity,  wide  
temperature  ranges  for  being  liquids, and  high  ionic  conductivity.  When  an  ionic  
liquid  is  used  as  a  reaction  solvent,  the  solute  is  solvated  by  ions  only,  where  
the  reaction  proceeds  under  quite  different  conditions  as  compared  to  using  
water  or  the regular  organic  solvents. Hence, they  are  expected  to  exhibit  
unconventional  reactivity,  and  their  applications  in  a  variety  of  organic  reactions  
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are  being  explored. Furthermore,  some  ionic  liquids  have  a  very  low  solubility  in  
water  and  polar  organic  solvents. Utilization  of  this  property  enables  recovery  and  
reuse  of  ionic  liquids,  after  extracting  the  product  with  an  organic  solvent. That  
can  help  to reduce  the  waste  of  traditional  solvents  which  are  rarely  reused.  
Moreover,  ionic  liquids  have  attracted  much  attention  as  safe  solvents,  due  to  
their  low  volatility. The following  are  some  reaction  examples  using  ionic  liquids.113                                                                                                                                                             
Diels-Alder  Reaction.                                                                                                                                  
The  Diels-Alder  reaction  between  cyclopentadiene  and  the  methyl  acrylate  ester  
has  been  reported.  In  the  Diels  Alder  reaction  using  1-ethyl-3-methylimidazolium 
chloride/chloroaluminate  [emimCl/(AlCl3)X],  the  endo / exo  ratio  of  the  products 
varies  largely, depending  on  the  ratio  of  emimCl/ (AlCl3)X. The  amount  of  endo 
form  increases  four-fold  with  the  acidic  emimCl/(AlCl3)X, compared  to  that  of  the  
basic  emimCl/(AlCl3)X).114,115  When  the  same  reaction  is  carried  out  with 1-butyl- 
3-methylimidazolium  tetrafluoroborate  (bmimBF4)  there  was  similar  reactivity  to  
Lewis  basic  emimCl/(AlCl3)X. 
Scheme 3.15. Diel-Alder Reaction. 
   
128                          129                                  130                                131                                  
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   Heck Reaction. 
In  the  Heck  reaction  using  palladium  catalysts,  polar  solvents   such  as  DMF  and 
acetonitrile  are  usually  employed, and  aryl  iodides  are  normally  used  as  
substrates. In  cases  where  the  less  expensive  but  less  reactive  aryl  bromides  or  
chlorides  are  employed, it  is  necessary  to  use  more  active  catalysts  or  add  
phosphine  ligands  in  order  to  retain  the  catalytic  activity. By  utilizing 1-butyl-3-
methylimidazolium  bromide  (bmimBr)  as a  solvent,  aryl  bromides  react  with  
styrene  to  afford  stilbenes  in  high  yields  without  adding  a  phosphine  ligand. 116  
Scheme 3.16. Heck Reaction                                                                                             
 
     132            133                                                         134 
Aldol Condensation Reaction                                                                                                    
The Aldol Condensation  reaction  using  ionic  liquids  has also been  reported.  In  the 
reaction  for  obtaining  2,4-dimethylhept- 2-enal 134  from  propanal  via  two  Aldol  
condensations,  the  conversion  values  of  the  ionic  liquid  phase  is  comparable  to a 
water  medium  in  the  Aldol I  reaction.  However,  the  product  selectivity  is  reduced,  
as  can  be  seen  (Scheme 3.17)  below. This  is  due  to  a  side  reaction  proceeding  
from  the  high  solubility  of  product 136  toward  the  ionic  liquid. In  contrast,  in  the  
Aldol II  reaction,  as  compared  with  the  reaction  in  water,  the  product  selectivity  
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in  ionic  liquids  are  increased. This  is  because  the  hydrogenated  product  of 136  is  
difficult  to  dissolve  in  water  but  is  easy  in  ionic  liquids. 117                                                                                                                                             
Scheme 3.17.  Aldol Condensation Reaction 
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Synthesis  of  Isopropyl glycosides 
 In  another  study,  trichloroacetamidate  donors  (TCA)  were  used  in  glycosylation  
reactions  in  [bmIm][PF6]  and  [emIm][OTf]  with  monosaccharide  derivatives.118  
(Scheme  3.18).                                                                                                      
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Scheme 3.18.  Synthesis of Isopropyl  Gycosides 
      
       140                                                                        141                                   
 
Synthesis of Furan Diol                                                                                                         
2-(D-glycero-1,2-dihydroxyethyl)  furan  142  is a potential  chiral  building  block  used  
as  an  intermediate  in  the  organic  synthesis  of  biologically  significant  
products.119,120 Monosaccharides  are  extremely  acid-labile  and  under hydrolytic  
conditions  lead  to  furans. Thus, in 1966,  the  first  transformation  of  D-glucal 106  to  
optically  active  furan  diol   was  reported,  using  H2O/HOAc  at  170 0C. 121,122  RTILs  
in  this  transformation  were  used  as  catalyst  promoters  with 10%  InCl3.3H2O  as  
the catalyst  and  acetonitrile as the solvent  at  room  temperature.  (Scheme 3.19)                                                                                                                                                          
Scheme 3.19. Synthesis of Furan Diol. 
 
                 106                                            142 
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3.3.4. The  Synthesis  of  Pyranobenzopyran  Using  Ionic  Liquids                                                                   
The  application  of  ionic  liquids  in  a variety  of   reactions  and  their  success  in  
obtaining  the  required  product  in   good  yields  encouraged  us  to  think  about  the  
use  of  ionic  liquids as  solvent  in  the  synthesis  of  pyranobenzopyrans. Three  
different  ionic  liquids  were  used, 1-butyl-3-methylimidazolium  tetrafluoroborate,                      
1-butyl-3-methylimidazolium  hexafluorophosphate  and 1-ethyl-3-methylimidazolium  
ethylsulfate, to  study  the  effect  of  the  different  anions  and  alkyl chain  lengths  on  
the  imidazolium  ion  in  the  yield  of  the  products.  The  choice  of  imidazolium  ionic  
liquids  was  due  to  their reported physical  properties and suitability  for  the  
reactants. The  ionic  liquids   based  on  the  [bmim]+  have  low  melting  points,  for  
example  The  [bmim]PF6  salt  has  a melting  point  of  58-60 0C  while  the  [bmim]  
BF4-  and  the  [emim] EtSO3-   salts  have  melting  points  of  15  and  -20 0C, 
respectively.102  These  ionic  liquids  have  low  viscosities, are air  and  moisture  stable  
and  are  easily  and  cheaply  synthesized. They  can  also  dissolve  a wide  range  of  
organic  and  inorganic  compounds  which  make  them  applicable  in  organic  
synthesis. These properties  have opened  up  the  avenue  of  using  them  as  
potential  replacement  solvents.  At   present,  the  most  widely  used    ionic  liquids  
are  the  species  based  on  1 –methylimidazole.  Examples  of  this  group  of  ionic  
liquids  are   [bmim]PF6   and  [bmim]BF4   which  are  widely  used  in  synthesis. They  
are   neutral  stoichiometric  compounds  and  they  are  stable  to  both  air  and  
moisture. Also, they are easily synthesized without great expense.  They  have  low  
densities,  viscosities,  and  they  are  liquids  below  room  temperature.102-105  Two  of  
our  ionic  liquids  were  synthesized  in  lab 1-butyl-3-methylimidazolium  
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tetrafluoroborate 144  (Scheme 3.20)   and 1-butyl-3-methylimidazolium  
hexafluorophosphate  (Scheme 3.21),  using  known  procedures  from  the  
literature.123  The  yields  obtained  for  both  of  them  were  92%.                                                                                                                           
Scheme 3.20. Synthesis of 1-Butyl-3-methylimidazolium Tetrafluoroborate  
 
       143                                                                                                          144 
     Scheme 3.21.  Synthesis of 1-Butyl-3-methylimidazolium  Hexafluorophosphate  
  
145                                                                                                          146 
 Cycloaddition  reactions  were  carried  out  using  the   previously  described  method,  
in  which  the  protected  D-glucals  were  added  to  the  o-hydroxybenzalimines  in  an  
ionic  liquid  solvent  (ILS)  and  catalyzed  with  scandium  triflate  at  room  
temperature. (Scheme 3.22).                                                                                                                          
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Scheme 3.22. Synthesis of Pyranobenzopyran  Using  Ionic  Liquids. 
 
     108                                     89                                              109 
OR = Acetyl, Silyl, Benzyl          ILS = 1-butyl-3-methylimidazolium tetrafluoroborate, 1-butyl-3-methylimidazolium  
hexafluorophospate, 1-ethyl-3-methylimidazolium  ethylsulfate                                                                                           
Tri-O-acetyl  and  tri-O-benzyl D-glucal  were  insoluble  in  the  ionic  liquids  whereas  
the  tris-O-tert-butyldimethylsilylglucal  give  a very  sticky  mixture  which  was  difficult  
to  stir. No  reaction  was observed  to  take  please  with  this  sugar  nor  was  product  
obtained. The  reason  for  the  failure  of  these  reactions  was  likely   the  higher  
polarity  and  viscosity  of   the  ionic  liquid.  With this in mind, we decided to use                    
D-glucal  due to its inherent polarity. (Scheme 3.23).   
Scheme 3.23 Synthesis of  Pyranobenzopyran   Using  D-glucal  in  Ionic  Liquids 
 
                                                                                                               
        108                                    89                                       109 
R = Bn, Ac, TBDMS 
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The  D-glucal  dissolved  well  in  both 1-butyl-3-methylimidazolium  tetrafluoroborate  
and 1-ethyl-3-methylimidazolium  ethylsulfate  ionic  liquids,  as  did  all  the  other  
components   of  the  reaction,  to  give  homogenous  mixtures  with  a brown  color. 
Though  the  mixtures  were  stirred  for  48  hours  the  TLC using  mixture of                         
(4:1 hexane/EtOAC,)  acetate)  did  not  show  the  formation of  any  product., If  the  
reaction  was  stirred  longer,  decomposition  of  the  imine  to  the  aniline  and  o-
hydroxybenzaldehyde  was  observed. We  concluded  that  our  procedure  was  not  
suitable  for  the  conversion  of  D-glucal,  and  we  decided  to  try  another  literature  
procedure  for  the  synthesis  of  pyranobenzopyrans.63  First,  we  stirred a  mixture  of  
o-hydroxybenzaldehyde,  triethyl  orthoformate  and  Sc(OTf)3  for  20  min  and  then  
added  it to  the  solution  of  the  D-glucal  in  ionic  liquid  (Scheme 3. 24). The  
reaction  was  stirred  for  72 h,  and  the  reaction  completion  was  monitored  by  thin  
layer  chromatography.  Many spots were observed  on  the  TLC. The  two  major  
spots  were  isolated  using   column  chromatography  and  were  identified  as  
chromene derivative  147 and  furan  diol 142. The  structures  of  those  molecule  and  
all  of  the  other  products  formed  were  determined  from 1D  and  2D, 1H  and 13C  
NMR  experiments.                                                                                                                          
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Scheme 3.24.  Addition Reactions of D-glucal and o-Hydroxybenzaldehydes 
 
     
       82                         106                                                 147                             142 
       R = H, Cl, Br, OMe, NO2, OH, Me 
The  Proposed  Mechanism  of  the  Reaction                                                                               
The  reaction   of  2-hydroxybenzaldehyde  with  triethyl orthoformate  probably  
proceeds  through  the  intermediate  formation  of  148  and  then  the  formation  of  
the  oxa- diene 149,  (step1).  In  the  other  hand  the  stirring  of  the  D-glucal  with  
Sc(otf)3   in  the  ionic  liquid  lead  to  the  formation  of  the  D-glucal  diene  150, 
(step2). The  addition  of  the  sugar  diene  150  that  react  as  dienophile  to  the  oxa-
diene  in  a [4+2]  cycloaddition  to   generate   the  oxygen-containing  six  member  ring 
147,  and  furan  diol  as  major by-product  .   
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Step1 Formation of Oxa  Diene 
 
        82                                                       148                              149 
                                                                                                                                                            
Step2 Formation of the D-glucal Diene 
    
                    106                                                 150 
Step 3  The Cycloaddition Reaction  
 
           149                            150                                         147 
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Reaction Optimization                                                                                                               
In  order  to  study  the  effect  of  substituent  on  the   synthesis  of  
pyranobenzopyrans  several  salicylaldehyde  derivatives  82a-82g   
 were reacted  with  glucal 106. Unfortunately  most  of  the  salicylaldehyde  derivatives  
have  moderate  to  zero  solubility  in  the  ionic  liquids  which  leads  to  a reduction  of  
the  yield  of  the   major  products  and  an  increase  in  the  yield  of  by-products. The 
yields for the  products  147a-147d   ranged  from  36%  to  79%. With  all  of  the  
soluble  salicylaldehyde  derivatives  and  glucal  addition  reactions,  furan  by-product 
142  was  also  obtained  (39-58%).  Acetonitrile  was  added  as  co-solvent  in  the  
reaction  to  improve  the  solubility  of   ionic  liquid  insoluble  salicylaldehyde  
derivatives  such  as  2-hydroxy-5-nitrobenzaldehyde,  2-hydroxy-5-
methylbenzaldehyde  and  2,5-dihydroxybenzaldehyde.  2-Hydroxy-5-nitrobenzaldehyde  
was  completely  dissolved  in  the  mixture  of  the  ionic  liquid  with  acetonitrile, 
whereas  2-hydroxy-5-methylbenzaldehyde  and  2,5-dihydroxybenzaldehyde  were  
partially  dissolved  but  no  product  was  formed  after  stirring  for 72  hours  at  room  
temperature. Our  success  in  the  synthesis  using  ionic  liquids  encouraged  us  to  
try  different   dienes,  E-chalcone 153,  was  first  prepared  as  the  starting  material  
using  the known  literature  procedure.124  (Scheme 3.25).  A  representative  
experimental  procedure  for  this  involved  a  room  temperature  reaction  between  
benzaldehyde 151,  acetophenone 152  and  a saturated  sodium  hydroxide  solution  
in  95%  ethanol.                                                                                                                                               
 
 76 
 
 
Scheme 3.25. Synthesis of  E-Chalcone 
 
151                                   152                                        153 
Once  the  E-chalcone 153  was  synthesized  we  added  it  to D- glucal 106  in  ionic  
liquid  in  the  presence  of  scandium  triflate  (Scheme 3.26).  The  E-chalcone 153  
was  insoluble  in  the  ionic  liquid   in  both  conditions,  at  room  temperature,  or   
when  it  was   heated  to  80 0C.                                                                                         
Scheme 3.26. The Reaction  Between  D-glucal  with  E-Chalcone. 
 
            153                                          106                                               154 
D-glucal 106  and  1-methoxy-3-trimethylsiloxy-1, 3-butadien 155   was  also  reacted  in  
ionic  liquid  solvent  in  the  presence  of  Sc(OTf)3. The  electron  donating  nature  of  
this  diene  is  known  to  confer  higher  reactivity  and  orientational  specificity  in  its  
reaction  with  unsymmetrical  dienophiles.125  We  first  conducted  this  reaction  at  
room  temperature  but  it  took  a long  time  (72  hours)  and a   low  yield  (56%)  was 
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obtained  for  the  main  product Then  we  heated  the  reaction  to  80 0 C  for  12  
hours  to  optimize  for  the  product. The resulting molecule,  2-5,8a-dihydroxy-
1(hydroxymethyl)-1, 4a, 5, 6, 7,8a-hexahydro-8H-isochromeneone 156  was  obtained  
in 76 %  yield  (Scheme 3.27).  Upon  our  successes  in this  reaction  we used  the  
microwave  reactor  to  provide  heat  and   shorten  the  reaction  time,  the  reaction  
mixture  was  heated  for a  range  of  time  from  2  to 10  minutes  at  80 0C  R = Bn, 
Ac, TBDMS had  occurred.                                                                                                                          
Scheme 3.27 Reaction of Danishefsky’s Diene with D-Glucal 
 
                   155                      106                                               156                  142 
In  general,  we  assumed  the   [4+2]  cycloaddition  reaction  would  take  place  
between  the  diene  and  the  unsaturated  carbons  in  D-glucal   but  the 1H NMR  and 
13C  NMR  showed  the  glucal  double  bonds  were  still  present  around  6  ppm  in   
all  the  predicted  structures.  The  tables  below  summarize  the 1H  and 13C  data  and 
illustrate  the  assigned  structures 147a-147d, 156. Then  we  believed  that  the  
reaction  occured  via  the  initial  formation  of  a  sugar  diene   that  reacts  as  a  
dienophile  where  the  other  reactants  in  a  [4+2]  cycloaddition  to  generate  the  
oxygen-containing  six-membered  ring. The  fact  that  D-glucal 106  could  participate  
as  both  the  diene  or  as  the  dienophile  in  these  ionic  liquid  mediated  reactions  
was  evidenced  by  the  formation  of  the  glucal  dimer 157  (Scheme 3.27). The  
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formation  of  furan  diol 142  can  also  be  accounted  for  via  an  acid  catalyzed  
elimination  such  as  that  leading  to  intermediate 157  or  a  similar  ring  opened  
analog.                                                                                                                                  
Scheme 3.28. Dimerization of D-Glucal. 
                                                              
     106                                                     157                       52                             
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Table 3.4. 1-(hydroxymethyl)-1H,10H-pyrano[4,3-b]chromenee-10,10a(4aH)-diol (9a) 
147a 
      
Atom  label 1H Chemical Shift 
(ppm) 
13C Chemical Shift 
(ppm) 
1 6.34 144.02 
2 4.74 106.23 
3 4.38 81.97 
4 4.77 100.30 
5 4.25 69.58 
6, 6’ 3.94-3.81 66.72 
7 5.96 68.98 
8  128.77 
9  130.93 
10 7.43 116.87 
11 6.90 128.77 
12 6.87 120.10 
13 7.22 130.93 
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Table 3.5. 12-chloro-1-(hydroxymethyl)-1H, 10H-pyrano[4,3-b]chromenee-10,10a(4aH)-
diol 147b  
      
Atom  label 1H Chemical Shift 
(ppm) 
13C Chemical Shift 
(ppm) 
1 6.35 143.11 
2 4.47 105.34 
3 4.42 81.04 
4  97.72 
5 4.29 68.60 
6, 6’ 3.91 55.8 
7 5.93 68.06 
8  11760 
9  129.71 
10 6.88 127.43 
11 7.22 129.47 
12  127.43 
13 7.42 129.47 
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Table 3.6.14-(hydroxymethyl)-12-methoxy-1H,10H- pyrano[4,3-b]chromenee-10, 
10a(4aH)-diol 147c 
              
Atom  label 1H Chemical Shift 
(ppm) 
13C Chemical Shift 
(ppm) 
1 6.35 144.03 
2 4.74 106.15 
3 4.41 81.90 
4  99.96 
5 4.35 69.53 
6, 6’ 3.90-3.80 66.72 
7 5.90 68.93 
8  124.88 
9  153.78 
10 6.80 116.49 
11 6.80 117.64 
12  113.71 
13 6.99 149.50 
14 3.72  
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Table 3.7. 12-bromo-1-(hydroxymethyl)-6 methoxy-1H, 10-H-pyrano[4,3-b]c10, 10a 
(4aH)-diol 147d 
     
Atom  label 1H Chemical Shift 
(ppm) 
13C Chemical Shift 
(ppm) 
1 6.38  
2 4,76 110.94 
3 4.25 81.89 
4  97.38 
5 3.84 69.62 
6, 6’ 3.84 66.73 
7 5.99 68.95 
8  126.51 
9  144.03 
10  144.03 
11 7.25 115.65 
12  149.31 
13 7.11 122.72 
14 3.89 56.86 
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Table 3.8. 1a-dihydroxy-7-(hydroxymethyl)-1, 4 a, 5, 6, 7, 8a-hexahydro-1H-
isochromene-1-one 156 
      
Atom  label 1H Chemical Shift 
(ppm) 
13C Chemical Shift 
(ppm) 
1 6.29 144.16 
2 4.75 103.83 
3 4.39 80.47 
4  98.95 
5 4.20 68.05 
6, 6’ 3.60 66.66 
7  68.34 
8, 8’ 2.13 31.21 
9 2.81 48.28 
10 5.06 204.1 
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Table 3.9. D-Glucal Dimer 157 
 
Atom  label 
  
1H Chemical Shift 
(ppm) 
13C Chemical Shift 
(ppm) 
1 6.28 143.36 
1, 3.36 79.20 
2 4.56 104.70 
2, 5.06 104.90 
3 3.10 69.60 
3, 4.83 143.25 
4  68.92 
4,  79.44 
5 3.60 79.94 
5, 3.60 79.70 
6a, 6b 3.98, 3.70 68.85 
6,a, 6,b 3.57 60.84 
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3.3.4. Summary  
In  this  research,  we  examined  three  imidazolium-based  ionic  liquids  as  solvents 
in  cycloaddition  reactions. The  choice  of  these   ionic  liquids  is  based  on  their  
features  such  as ease  of  modifications,  stability  under  acidic  conditions.126                           
1-butyl-3-methylimidazolium  tetrafluoroborate   (Table 3.10)  and 1-ethyl-3-
methylimidazolium  ethylsulfate  ionic  liquid  (Table 3.11),                                                                                                                       
readily  solubilized  D- glucal 106,  o-hydroxybenzaldehyde  and  its  derivatives,  triethyl   
orthoformate  and  Sc(OTf)3   whereas  the  ionic  liquid 1-butyl-3-methylimidazolium  
hexafluorophospate  was  very  poor  at  solubilizing  those  reagents. The  difference  in  
these  three  RTILs  and  their  solubilizing  ability  for  D-glucal 106  is  a good  example  
of  the  tunable  properties  of  ionic  liquids. In  general, we  observed  the  yields  from 
1-ethyl-3-methylimidazolium  ethylsulfate  were  much  better  due  to  the  higher  
solubility  of  D-glucal  than  in  the  other  solvents.  In  this  medium,  the  difference  in  
the  viscosity of the IL  determines its  reaction  rates with D-glucal. The  reactant  
particles  diffuse  faster  in  less  viscous  solvents  and  can  collide  at  a higher  
frequency  per  unit  time. Thus  the  reaction  rates  decrease  rapidly  with  the  
increase  of  solvent  viscosity. The  viscosity  of 1-ethyl-3-methylimidazolium  
ethylsulfate  is 122  mpa  where  the  viscosity  for 1-butyl-3-methylimidazolium  
tetrafluroborate 135  mpa.127 
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Table 3.10. The Result Obtained Using the 1-butyl-3-methylimidazolium 
Tetrafluoroborate Ionic Liquid Solvent 
Entry      Diene             Product                                                   % Yield                By-product          % Yield 
1-                                   51                          29      
2-                57                     “                                41                                                            
3-          53                    “                                32                                                                               
4-             36                     “                              53               
5-                                61                    “                              23                                           
6-                        32                       “                             53                                                                                                                                                                                 
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Table 3.11. Cycloaddition Reactions with 1-ethyl-3-methylimidazolium ethylsulfate Ionic 
Liquid  
Entry        Diene                      Product                                       % Yield            By-product                % Yield 
1-                                       73                             22 
 2-                 78                                “                             18                                                            
3-           72                             “                              21                                                                              
 4-                      58                              “                                  37               
 5-                                76                                “                                 17                                           
 6-                               32                             “                                 53                                                                                                                                                                                 
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Summary 
The  reaction  of  carbohydrates  in  organic  solvents  typically  requires  protection  of  
the  hydroxyl  groups  as  non-polar-moieties  to  enhance  their  solubility. Later, a 
subsequent  deprotection  step  is  carried  out  to  remove  the  protecting  groups. In  
this  part  of  our  research  we  have  been  able  to  synthesize a  series of  
pyranobenzopyrans  147a-147d  in  modest  yields. Furan  diol 142  was  isolated  as  
the  major  byproduct  from  these  reactions. Lewis  acid-catalyzed  cycloaddition  
reactions  of  D-glucal 106  with  different  dienes  were  carried  out  in  room  
temperature  ionic  liquids. The products obtained from these reactions are shown in 
Table 3.10. 
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Chapter 4 
 Conclusion 
 
4.1. Summary 
The  goal  of  this  project  was to  develop  a  method  for  the  synthesis  of  
pyranobenzopyrans  and  carbohydrate-fused  heterocyclic  compounds. This  was  
accomplished  via  a  [4+2]  cycloaddition  reaction  to  generate  the  oxygen-
containing  six-membered  ring  by  the addition  of  the  imine  64;                                          
o-hydroxybenzaldimine  and  its derivatives  to  glucals  in  organic  solvent  under   
catalysis  by  scandium  triflate. The  conventional  method  and  microwave  reactor  
method  were  initially  used  to  achieve  this  goal,  but  no  reaction  was  observed  in 
both  cases  The  failure  of  this  reaction  under  these  cases  may  due  to  the  sugar  
protecting  groups  such  as  acetyl, benzyl  and  t-butyldimethylsilyl  that  made  steric  
hindrance  and  inhibited  the  reaction. Then  new  methodology  was  developed  and  
an ionic  liquid  was  used  as  solvent  to  dissolve  the  D-glucal  and  the  other  
reactants.  A  series  of  pyranobenzopyrans  have  been  prepared  via  Lewis  Acid  
catalyzed  cycloaddition  reactions  of  D-glucal  and  o-hydroxybenzaldehyde  and  its  
derivatives  in  room  temperature  imidazolium  ion-based  ionic  liquid  solvents. 
Different  o-hydroxybenzaldehyde  derivatives  82a-82g  were  tested  to  study  the   
effect  of  the  substituents  on  the  rate  of  the  reaction.   Four products were  
obtained 147a-147d  in  poor  to   moderate  yields. Because  2-hydroxy-5-
nitrobenzaldehyde,  2-hydroxy-5-methylbenzaldehyde  and  2,5-dihydroxybenzaldehyde  
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were  insoluble  in  the  ionic  liquids,  no  product  was  obtained  from  their  reaction  
with  D-glucal.  Danishefsky’s  Diene,  and 1-methoxy-3-trimethylsiloxy-1, 3-butadiene 
155,  were  also  reacted  in  ionic  liquids  and  the  product  2-5,8a-dihydroxy-
1(hydroxymethyl)-1,4a, 5, 6, 7,8a-hexahydro-8H-isochromeneone 156  was  obtained  
in  moderate  yield. In  these  reactions,  the  glycal  itself   was  found  to  serve  as  a 
diene   with  another  molecule  of  glycal  as  the  dienophile to  form  an  interesting  
sugar  dimer.                                                                                                                              
In   conclusion,  we  successfully  synthesized  pyranbenzopyran  derivatives  and  their  
structures  were  confirmed  by  using 1-D 1H  and  2-D 1H  and  13C  NMR   
4.2. Experimental Section  
General  methods:  Proton  nuclear  magnetic  resonance  (1H NMR)  spectra  were 
recorded  on  a Varian  Inova  (500 MHz)  spectrometer.  NMR  samples  were  
dissolved  in  d6 -acetone,  d1-chloroform  or  d6-DMSO  and  chemical  shifts  were  
reported  in  ppm  relative  to  the  residual  non-deuterated  solvent  (acetone  methyl  
group  at  2.05 ppm)  or  to  the  methyl  protons  on  tetramethylsilane  (TMS, 0.00 
ppm). 1H NMR  data  are  reported  as  follows: chemical  shift, integration,  multiplicity   
(s = singlet; d = doublet; dd =  doublet  of  doublet;  ddd = doublet  of  doublet  of  
doublets; m = multiplet), coupling  constant,  and  assignment. 13C NMR were  recorded  
on  the  same  instrument  (125 MHz). The 13C  chemical  shift  were reported  relative  
to  the  references  at  29.84,  77.23  and  39.51 ppm,  respectively.  All  the  NMR  
experiments  were  run  at  room  temperature  (25 0C)  and  assignments  were  done  
by  using  gCOSY  and  gHMQC. The mass spectra were obtained at the University of 
Illinois (Champaign-Urbana). Both  the  higher  resolution  and  the  low  resolution  
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mass  spectra  were  obtained  by  ESI  (electron spray ionization). Melting  points  (mp)  
were  measured  on  a Mel-Temp  melting  point  apparatus  (Laboratory  Devices, Inc., 
USA). The optical rotations were recorded on automatic polarimeter (Rudolph 
Instruments, New Jersey USA). Reactions  were  monitored  by  thin-layer  
chromatography  (TLC)  on  0.25 mm  silica  gel  coated  aluminum  sheets  60  F254  
(Analtech). Silica gel (particle size 40–63 Å, 230–400 mesh) (Silicycle) was used for 
flash column chromatography.  Preparative  thin-layer  chromatographic  separations  
were  carried  out  on  2000  mm  silica  gel  coated  glass  plates  60  F254  (Analtech). 
All  the  reactions  were  carried  out  in  oven-dried  glassware  under  nitrogen.                    
D-glucal  was  prepared  from  commercially-available 3, 4, 6-tri-O-acetyl-D-glucal  
(Aldrich Chemical Co.). The  ionic  liquids  were  prepared  using 1-methylimidazole,               
1-bromobutane, sodium  tetrafluoroborate  or sodium  hexafluorophospate  at   80 0C             
All  the  starting  materials  and  reagents  were  obtained  from  Alfa  Aesar  and  Sigma  
Aldrich  Chemical  Companies. 4.2.1. Representative Experimental Procedures 
3.2.1. 1-(hydroxymethyl)-1H,10H-pyrano[4,3-b]chromenee-10, 10a(4aH)-diol (147a).                     
A mixture  of  o-hydroxybenzaldehyde  8a (287 µL, 2.7 mmol),  triethyl  orthoformate  
(558 µL, 2.7 mmol)  and  scandium  triflate  (66 mg)  was  stirred  in  5 mL of 1-butyl-3-
methyimidazolium  tetrafluoroborate  or  1-ethyl-3-methylimidazolium  ethylsulfate  for  
20 min  then  (400  mg,  2.7 mmol)  D-glucal 106  was  added  to  the  mixture. The  
resulting  mixture  was  stirred  at  ambient  temperature  until  complete  conversion  
was  indicated  by  TLC. The  reaction  mixture  was  quenched  with  water  (20 mL)  
and  extracted  with  ethyl  acetate  (3 x 10 mL);  the  combined  organic  extracts  were  
dried  over  anhydrous  sodium  sulfate,  and  concentrated  in  vacuo. The  crude  
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product  was  purified  by  column  chromatography  using  mixture  of                                  
(98:2 CHCl3/CH3OH)  followed  by  repurification  on  a  2000  µm  silica  gel  thin  layer  
chromatography  plate.  All  subsequent  reported  yields  were  from  reactions  
conducted  in  1-butyl-3-methyimidazolium  tetrafluoroborate.  NMR  assignments  refer 
to  the  following  ring  positions: 
 
The  final  product  147a  was  a  white  powder  (0.376  g, 1.38  mmol,  51% ):  mp 118  
0C:  Rf (98:2  CHCl3 /CH3OH): 0.36;  [α]D 21`+ 8.6 (c 0.75, CHCl3); 1H  NMR  (500 MHz, 
d6  acetone) δ 7.22  (m, 2H, H-13, H-10, Ar), 7.09  (m, 2H, H-11,H-14 Ar), 6.34  (dd, 1H, 
J1,2 = 6.0, J1,3= 1.5 Hz, H-1),  5.96  (s, 1H, H-7), 4.74  (dd, 1H, J2,1= 6.0 Hz, J2,3= 1.5 
Hz, H-2), 4.38  (ddd, 1H, J = 6.5  Hz, J3,2 = 2.0 Hz, J3,1=1.5 Hz, H-3 ), 4.25  (dd, 1H, 
J5,6 = 10.0 Hz, J5,  6’= 5.0Hz, H-5), 3.94-3.81 (m, 2H, H-6, H-6’); 13C  NMR  (125 MHz, 
d6 acetone)  δ 144.02  (C-1), 130.93  (2C) (C-13, C-9), 128.77  (2C)  (C-11, C-8), 
120.10 (C-12), 116.87  (C-10), 106.23  (C-2), 100.30  (C-4),  81.97  (C-3),  69.58  (C-5),  
68.98  ( C-7),  66.72  ( C-6 ).  HRMS (ESI):  Calcd.for C13H14O5  for (M+Na)+ 273.0741. 
Found 273.0739. Compound 142  (0.100 g, 0.78 mmol, 29%)  was  also  isolated  as  a  
colorless  oil:  Rf  (98:2 CHCl3/CH3OH): 0.48. The 1H  NMR  (500 MHz, CDCl3)  was  in  
good  agreement  with  previously  reported  data  for  this  compound. 13C NMR (125 
MHz, d6-acetone) 153.59 (C1), 141. 55 (C4), 110.18  (C2), 106. 42 (C3), 63.06 (C1’), 
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42.43  (C2’); HRMS (ESI): Calcd  for  C6H8O3  for  (M + H)+ 128.04735. Found 
128.04773.  
 3.2.2. 8-chloro-1-(hydroxymethyl)-1H, 10H-pyrano[4,3-b]chromenee-10,10a(4aH)-
diol (147b).  
The  title  compound  was  obtained  as  white  powder  (0.473 g, 1.5 mmol, 57%) :  mp 
71 0C: Rf  (98:2 CHCl3 /CH3OH): 0.38;  [α]D22 - 9.7(c 0.75, CHCl 3); 1H  NMR  (500 MHz, 
d6 acetone) δ 7.42  (d, 1H, J1 3,11 = 1.5 Hz, H-13, Ar), 7.22  (dd, 1H, J 11,10 =6.5 Hz, 
J11,13 =2.5 Hz, H-11, Ar), 6.88  (d, 1H, J10,11 =9.0 Hz, H-10, Ar), 6.35  (d, 1H, J1,2 = 
6.0 Hz, H-1),  5.93  (s, 1H, H-7),  4.74  (dd, 1H, J2,1= 6.0 Hz, J2,3= 1.5 Hz, H-2),  4.42  
(brs, 2H, H-3, OH),  4.29  (dd, 1H, J5,6 =10.0 Hz, J5,6’= 5.0 Hz, H-5), 3.91 (m, 2H, H-6, 
H-6’); 13C NMR  (125 MHz, d6 acetone) δ 154.47 (C-12), 143.11 (C-1), 129.71 (2C) (C-
13, C-9), 127.43 (2C) (C-11, C-12), 105.34  (C-2), 97.72  (C-4), 81.04  (C-3), 68.60  (C-
5),  68.06  (C-7), 55.80  (C-6); HRMS  (ESI): Calcd.  for C13H14O5   for  (M+Na)+ 
307.0352. Found 307.0349. Elution also afforded 142 (0.142 g, 1.11 mmol, 41%).                          
3.2.3. 1-(hydroxymethyl)-8-methoxy-1H, 10H- pyrano[4,3-b]chromenee-10, 
10a(4aH)-diol (147c).  
The  title  compound  was  obtained  as  white  powder  (0.434 g, 1.43 mmol, 53%) : mp 
87 0C: Rf  (98:2 CHCl3 /CH3OH): 0.40; [α]D21+ 8.9 (c 0.75, CHCl3); 1H NMR (d6 acetone) 
δ 7.66 (brs, 1H, OH), 6.99 (d,1H, J13,11 = 2.0 Hz, H-13, Ar,), 6.80 (m, 2H, H-10,11, Ar), 
6.35 (d, 1H, J1,2 = 4.5 Hz, H-1), 5.90 (s, 1H, H-7), 4.74 (dd, 1H, J2,1 = 5.0 Hz, J2,3 = 
1.5 Hz, H-2), 4.45 (brs, 1H , OH), 4.41 (dd, 1H, J3,2 = 6.0 Hz, J3,1 = 2.0 Hz, H-3), 4.35 
(dd, 1H, J5,6 = 10.0, J5,6’ = 5 Hz, H-5), 3.90- 3.80 (m, 2H, H-6, H-6’), 3.72 (s, 3H, H-
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14); 13C NMR  (d6 acetone)  δ 153.78 (C-9), 149.50 (C-13), 144.03, (C-1) 124.88 (C-8), 
117.64 (C-11), 116.49 (C-10), 113.71 (C-13), 106.15 (C-2), 99.96 (C-4), 81.90 (C-3), 
69.53 (C-5), 68.93 (C-7), 66.72  (C-6), 55.98  (C-14); HRMS (ESI): Calcd. for C14H16O6   
for  (M+Na)+ 303.0839.  Found 303.0845.  Furan diol 142 was also  obtained  (0.110 g, 
0.87  mmol, 32%).                                                                                                                                       
3.2.4. 8-bromo-1-(hydroxymethyl)-6 methoxy-1H, 10H-pyrano[4,3-b]c10, 10a  
(4aH)-diol 147d The  title  product  was  obtained  as  white  powder  (0.349 g, 0.97 
mmol, 36 %); mp  92 0C; Rf (98:2 CHCl3 /CH3OH): 0.42; [α]D22+ 12.4 (c 0.75, CHCl3); 
1H NMR  (d6 acetone)  δ 7.25 (d, 1H, J11,13 = 2.5 Hz, H-11 Ar), 7.11 (d, 1H, J13,11 = 
2.5 Hz, H-13 Ar), 6.38  (dd, 1H, J1,2 = 6.0 Hz, J1,3 =1.5 Hz, H-1), 5.99 (s, 1H, H-7), 
4.76 (dd, J2,1 = 6.0 Hz, J2,3 = 1.2 Hz, H-2), 4.25 (dd, 1H, J3,2 = 1.5 Hz, J3,1 = 1.2 Hz, 
H-3), 3.89 (s, 3H, H-14), 3.84 (m, 3H, H-5, 6, 6’); 13C NMR  (d6 acetone)  δ 149.31 (C-
12), 144.48  (C-1), 144.03  (2C)(C-9, C-10), 126.51 (C-8), 122.72  (C-13), 115.65  (C-
11), 110.94  (C-12), 106.22  (C-2), 97.38 (C-4), 81.89 (C-3), 69.62 (C-5) 68.95 (C-7), 
66.73 (C-6), 56.86 (C-14). HRMS (ESI): Calcd for C14H15O6   for (M+H)+ 359.0115. 
Found 359.0130. Compound 142 was also isolated (0.183 g, 1.43 mmol, 53%). 
3.3. 8a-dihydroxy-1-(hydroxymethyl)-1, 4 a, 5, 6, 7, 8a-hexahydro-8H-isochromene-
8-one (156). 
 A  mixture  of  D-glucal  106  (400 mg, 2.7 mmol), 1-methoxy-3-trimethylsiloxy-1 3-
butadiene 155  (517 mg 3.0 mmol)  and  scandium  triflate  (66 mg)  in  1-butyl-3-
ethyimidazolium  tetrafluoroborate (5 mL)  was  stirred   overnight  at  80 0C.  After  
completion  of  the  reaction, as indicated  by TLC  using  mixture  of  98:2  
(CHCl3/CH3OH), the  reaction  mixture  was quenched  by  addition  of  water  (20 mL)  
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and  extracted  with  ethyl  acetate  (3 x 10 mL). The combined  organic  layers  were  
dried  over  anhydrous  sodium  sulfate,  and  the  resulting product  was  purified  by  
column  chromatography  using  mixture  of  98:2  (CHCl3/CH3OH) followed  by  a 
second purification on a 2000  µm  thin  layer SiO2  chromatography  plate  and  the  
pure  product  was concentrated  in  vacuo. The  final  product  156  was  white  powder  
(0.354 g, 1.6 mmol, 61%) : mp 95 0C; Rf  (98:2 CH3OH/CHCl3): 0.32; [α] D21 + 36.2 (c 
0.80 ,CHCl3); 1H NMR (500 MHz,CDCl3) δ 6.15  (dd,1H, J1,2 = 6.5, J1,3 = 2.0 Hz, H-1), 
4.92 (dd, 1H, OH), 4.60  (dd,1H, J2,1 = 6.0, J2,3 = 2.5 Hz, H-2), 4.24 (ddd, 1H, J3,7= 
5.5, J3,2= 2.5 Hz, J3, 1 -=1.2 Hz, H-3), 4.05 (dd, 1H, J5,6 =10.0, J5, 6a = 5.5 Hz, H-5), 
3.60  (m, 1H, H-7), 3.50  (m, 2H, H-6, H-6a), 2.67 (dd, 2H, J= 5.00 Hz, H-9, H-9a ),  2.13 
(m, 2H, H-8, H-8a). 13C  NMR  (125 MHz, CDCl3)  204.1 (C-10), 144.16  (C-1), 103.83  
(C-2), 98.95  (C-4), 80.47   (C-3),  68.34 (C-7), 68.05  (C-5),  66.66  (C-6), 48.28  (C-9), 
31.21  (C-8). HRMS (ESI): Calcd  for  C10H14O5  for  (M+H+)  215.0917. Found 
215.0919; Prior elution  also  gave 142 (0.08 g, 0.62  mmol, 23%).                                             
3.4. D-Glucal Dimer (157).                                                                                                                  
A  mixture  of  D-glucal 106  (400 mg, 2.7 mmol)  and  scandium  triflate  (66 mg)  was  
stirred  in of  1-butyl-3-methyimidazolium tetrafluoroborate  (5 mL) overnight  at  80 0C. 
The  crude  product  was  purified  by  column  chromatography  (92:8 CHCl3/CH3OH)  
to  afford  product 157  as  a  white  solid  (0.221 g, 0.86 mmol, 32 %) : mp  78 0C: Rf  
(92:8 CHCl3 /CH3OH): 0.29; 1H NMR  (d6 DMSO) δ 6.28  (dd, 1H, J1,2 = 6.0 Hz, 
J1,3=1.5 Hz, H-1), 5.06  (brd, 1H, J2’, 3’= 4.5 Hz, H-2’), 4.83 (brd, 1H, J3’, 2’ = 4.5 Hz, 
H-3’), 4.56 (m, 2H, H-2, H-4’), 3.98 (brs, 1H, H-6a), 3.70 (brs, 1H, H-6b), 3.57 (d, 2H, 
J6’a,6’b = 10.5 Hz, H-6’a, H-6’b), 3.36 (brs, 1H, H-5), 3.10  (m, 1H, H-5’); 13C NMR 
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(CDCl3) δ = 143.36 (C-1), 143.25 (C-3’), 104.90 (2C) (C-2, C-2’), 79.94 (C-5), 79.70 (C-
5’), 79.44  (C-4’), 79.20  (C-1’) 69.60  (C-3), 68.92  (C-4), 68.85  (C-6), 60.84  (C-6’) 
LRMS (ES+): Calcd  C12H16O6  for  (M+Na)+  256.08. Found 256.09. Compound 142 
was  also  obtained  (0.183 g, 1.43  mmol, 53%). 
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4.3. Appendix 
1H  and  13C NMR  Spectra  of  the  produced  compounds  
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